arakom的个人主页 - 老虎社区

arakom

arakom

暂无个人介绍

IP属地：未知

50关注

13粉丝

0主题

0勋章

2021-12-23

Like pls

Wall St mints strong gains on rosy economic data, encouraging Omicron update

2021-12-21

Sure

3 Growth Stocks That Could Skyrocket 50% or More in 2022, According to Wall Street

2021-12-21

Like pls

抱歉，原内容已删除

2021-12-20

Like pls

Society Pass surged nearly 70% in premarket trading

2021-12-20

Like

Novavax shares rose more than 8% in premarket trading

2021-12-20

Like pls

Nike, Micron, BlackBerry, CarMax, and Other Stocks for Investors to Watch This Week

2021-12-18

Like pls

EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%

2021-12-18

Like pls

Why Pfizer and Johnson & Johnson Fell on Friday

2021-12-18

Like pls

Wall Street ends down after mostly negative week

2021-12-16

Like

Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum

2021-12-16

Buy?

Roku Stock Tumbled. Some See a Buying Opportunity.

2021-12-16

Like

Wall St ends higher; Fed to end bond purchases in March

2021-12-15

Good. Pls like

抱歉，原内容已删除

2021-12-15

Yes!

抱歉，原内容已删除

2021-12-15

Like pls

What Does The Giphy Deal Block Mean For Meta's Business Outlook

2021-12-15

Like

Warren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap

2021-12-14

Oh

Footprint Agrees to $1.6 Billion Gores SPAC Deal as Koch Invests

2021-12-14

Wow

4 Stocks Insiders Are Selling

2021-12-14

Like

Swiss to start Pfizer/BioNTech jab for children aged 5-11 in January

2021-12-14

Like pls

2 Warren Buffett Dividend Stocks to Buy Right Now

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4093495894883950","uuid":"4093495894883950","gmtCreate":1630392830454,"gmtModify":1637939182496,"name":"arakom","pinyin":"arakom","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":13,"headSize":50,"tweetSize":41,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":691541703,"gmtCreate":1640224124906,"gmtModify":1640224153015,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691541703","repostId":"2193113147","repostType":4,"repost":{"id":"2193113147","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213688,"share":"https://www.laohu8.com/m/news/2193113147?lang=&edition=full","pubTime":"2021-12-23 06:54","market":"us","language":"en","title":"Wall St mints strong gains on rosy economic data, encouraging Omicron update","url":"https://stock-news.laohu8.com/highlight/detail?id=2193113147","media":"Reuters","summary":"* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22  - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of","content":"<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St mints strong gains on rosy economic data, encouraging Omicron update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St mints strong gains on rosy economic data, encouraging Omicron update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BK4568":"美国抗疫概念",".DJI":"道琼斯","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药",".IXIC":"NASDAQ Composite","COMP":"Compass, Inc.","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193113147","content_text":"* Consumer confidence index increases in December\n* U.S. Q3 economic growth revised slightly higher\n* Tesla jumps as CEO Musk says he has sold 'enough' stock\n* Pfizer rises as oral COVID-19 pill wins approval\n* Indexes up: Dow 0.74%, S&P 1.02%, Nasdaq 1.18% \nDec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.\nThe S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.\nA South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.\n“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.\nThe Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.\nAll major S&P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.\nTesla Inc shares rose 7.5%, boosting the S&P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.\nU.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.\nOther reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.\nIn another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.\nThe benchmark S&P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.\nThe market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”\nAdvancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.\nThe S&P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.\nAbout 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":812,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693411797,"gmtCreate":1640060295165,"gmtModify":1640060953207,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Sure","listText":"Sure","text":"Sure","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693411797","repostId":"2192358181","repostType":4,"repost":{"id":"2192358181","pubTimestamp":1640055937,"share":"https://www.laohu8.com/m/news/2192358181?lang=&edition=full","pubTime":"2021-12-21 11:05","market":"us","language":"en","title":"3 Growth Stocks That Could Skyrocket 50% or More in 2022, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2192358181","media":"Motley Fool","summary":"There are good reasons for Wall Street analysts to be bullish about these stocks.","content":"<p>Want to have a really happy new year? Invest now in stocks that are likely to really take off in 2022. Granted, that's easier said than done. There's no way to know for sure which stocks will perform well in the future.</p>\n<p>However, you can get some ideas from the analysts getting paid big bucks to research companies from top to bottom. Here are three growth stocks that will skyrocket 50% or more in 2022, according to Wall Street.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F657145%2F2022-businessman-with-charts.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"423\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>1. Sea Limited</h2>\n<p>The consensus 12-month price target for&nbsp;<b>Sea Limited</b> (NYSE:SE) reflects an upside potential of 89%. Sea wasn't too far away from achieving that target in October. However, the stock has plunged more than 40% from its high -- in part due to the company badly missing Q3 earnings expectations but mainly because of the overall sell-off of growth stocks.</p>\n<p>Sea's past success has been primarily driven by its <i>Free Fire</i> mobile game. Although <i>Free Fire</i> was launched four years ago, it's still the highest-grossing mobile game in India, Latin America,and Southeast Asia, according to App Annie. It has also been the highest-grossing mobile battle royale game in the U.S. for three consecutive quarters. Sea expects even more growth as it rolls out new features.</p>\n<p>But don't think of Sea Limited as just a video game stock. The company's Shopee e-commerce platform dominates in the Southeast Asia and Taiwan markets. It's also made significant headway in Latin America.</p>\n<p>Sea also has SeaMoney. It's a top digital payments and financial services provider in Southeast Asia. In the third quarter of 2021, SeaMoney's total payment volume more than doubled year over year.</p>\n<p>Gaming, e-commerce, and digital payments are all strong growth markets. There aren't many companies that have the potential to win in all three, but Sea Limited could.</p>\n<h2>2. Teladoc Health</h2>\n<p><b>Teladoc Health</b>'s (NYSE:TDOC) shares are down more than 50% year to date. But Wall Street thinks this virtual care leader could rebound in a major way in 2022. The consensus price target for Teladoc reflects an upside potential of nearly 66%.</p>\n<p>Why has Teladoc fallen so much? One main factor is that some investors thought that the end of COVID-19 lockdowns would lead to slowing growth. While Teladoc did experience some slowing, its business continues to perform very well.</p>\n<p>The company's near-term prospects look quite good. Teladoc's contract with HCSC, the fifth-biggest health insurer in the U.S., goes into effect in January 2022. Primary360, Teladoc's virtual primary care service, also continues to gain momentum.</p>\n<p>Teladoc's long-term prospects should be even better. We're still only in the early innings of the adoption of virtual care. Sure, there are other companies competing against Teladoc. However, the company has a wider moat than you might think as the largest player in the industry.</p>\n<h2>3. <a href=\"https://laohu8.com/S/PYPL\">PayPal</a></h2>\n<p><b>PayPal Holdings</b> (NASDAQ:PYPL) has fallen more in recent months than it has since the fintech stock first traded publicly as a stand-alone entity in 2015. Analysts think this decline will be only temporary, though. The consensus price target for PayPal is 50% higher than its current share price.</p>\n<p>Wall Street's optimism could be well-founded. PayPal ranks as the most accepted digital wallet in the world. More than 75% of the top 1,500 biggest merchants allow customers to pay with PayPal. As e-commerce grows, so will PayPal.</p>\n<p>New features should enable PayPal to gain even more momentum. The app's cryptocurrency wallet has been a big hit. PayPal plans to launch high-yield savings to the app in early 2022.</p>\n<p>PayPal's Venmo mobile payment app should also enjoy a significant boost next year. <b>Amazon.com</b> will allow customers to make purchases with their Venmo accounts beginning in 2022.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Growth Stocks That Could Skyrocket 50% or More in 2022, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Growth Stocks That Could Skyrocket 50% or More in 2022, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 11:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/20/growth-stocks-skyrocket-2022-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Want to have a really happy new year? Invest now in stocks that are likely to really take off in 2022. Granted, that's easier said than done. There's no way to know for sure which stocks will perform ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/20/growth-stocks-skyrocket-2022-wall-street/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4504":"桥水持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4106":"数据处理与外包服务","BK4554":"元宇宙及AR概念","BK4503":"景林资产持仓","SE":"Sea Ltd","BK4524":"宅经济概念","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4167":"医疗保健技术","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","PYPL":"PayPal","BK4567":"ESG概念","TDOC":"Teladoc Health Inc.","BK4527":"明星科技股","BK4085":"互动家庭娱乐"},"source_url":"https://www.fool.com/investing/2021/12/20/growth-stocks-skyrocket-2022-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192358181","content_text":"Want to have a really happy new year? Invest now in stocks that are likely to really take off in 2022. Granted, that's easier said than done. There's no way to know for sure which stocks will perform well in the future.\nHowever, you can get some ideas from the analysts getting paid big bucks to research companies from top to bottom. Here are three growth stocks that will skyrocket 50% or more in 2022, according to Wall Street.\nImage source: Getty Images.\n1. Sea Limited\nThe consensus 12-month price target for Sea Limited (NYSE:SE) reflects an upside potential of 89%. Sea wasn't too far away from achieving that target in October. However, the stock has plunged more than 40% from its high -- in part due to the company badly missing Q3 earnings expectations but mainly because of the overall sell-off of growth stocks.\nSea's past success has been primarily driven by its Free Fire mobile game. Although Free Fire was launched four years ago, it's still the highest-grossing mobile game in India, Latin America,and Southeast Asia, according to App Annie. It has also been the highest-grossing mobile battle royale game in the U.S. for three consecutive quarters. Sea expects even more growth as it rolls out new features.\nBut don't think of Sea Limited as just a video game stock. The company's Shopee e-commerce platform dominates in the Southeast Asia and Taiwan markets. It's also made significant headway in Latin America.\nSea also has SeaMoney. It's a top digital payments and financial services provider in Southeast Asia. In the third quarter of 2021, SeaMoney's total payment volume more than doubled year over year.\nGaming, e-commerce, and digital payments are all strong growth markets. There aren't many companies that have the potential to win in all three, but Sea Limited could.\n2. Teladoc Health\nTeladoc Health's (NYSE:TDOC) shares are down more than 50% year to date. But Wall Street thinks this virtual care leader could rebound in a major way in 2022. The consensus price target for Teladoc reflects an upside potential of nearly 66%.\nWhy has Teladoc fallen so much? One main factor is that some investors thought that the end of COVID-19 lockdowns would lead to slowing growth. While Teladoc did experience some slowing, its business continues to perform very well.\nThe company's near-term prospects look quite good. Teladoc's contract with HCSC, the fifth-biggest health insurer in the U.S., goes into effect in January 2022. Primary360, Teladoc's virtual primary care service, also continues to gain momentum.\nTeladoc's long-term prospects should be even better. We're still only in the early innings of the adoption of virtual care. Sure, there are other companies competing against Teladoc. However, the company has a wider moat than you might think as the largest player in the industry.\n3. PayPal\nPayPal Holdings (NASDAQ:PYPL) has fallen more in recent months than it has since the fintech stock first traded publicly as a stand-alone entity in 2015. Analysts think this decline will be only temporary, though. The consensus price target for PayPal is 50% higher than its current share price.\nWall Street's optimism could be well-founded. PayPal ranks as the most accepted digital wallet in the world. More than 75% of the top 1,500 biggest merchants allow customers to pay with PayPal. As e-commerce grows, so will PayPal.\nNew features should enable PayPal to gain even more momentum. The app's cryptocurrency wallet has been a big hit. PayPal plans to launch high-yield savings to the app in early 2022.\nPayPal's Venmo mobile payment app should also enjoy a significant boost next year. Amazon.com will allow customers to make purchases with their Venmo accounts beginning in 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693411287,"gmtCreate":1640060278217,"gmtModify":1640060952409,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693411287","repostId":"2192358181","repostType":4,"isVote":1,"tweetType":1,"viewCount":690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693805356,"gmtCreate":1639994360595,"gmtModify":1639994618924,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693805356","repostId":"1150927570","repostType":4,"repost":{"id":"1150927570","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639992300,"share":"https://www.laohu8.com/m/news/1150927570?lang=&edition=full","pubTime":"2021-12-20 17:25","market":"us","language":"en","title":"Society Pass surged nearly 70% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1150927570","media":"Tiger Newspress","summary":"Society Pass surged nearly 70% in premarket trading.\n Society Pass Incorporated, a leading Southeast","content":"<p>Society Pass&nbsp;surged&nbsp;nearly&nbsp;70%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/72c0eec298020d16e124a5d7b04f0b58\" tg-width=\"716\" tg-height=\"615\" width=\"100%\" height=\"auto\"> Society Pass Incorporated, a leading Southeast Asian data-driven loyalty platform, today announced that the Company will be added to the Russell 2000® Index, effective at the open of the U.S. markets on December 20, 2021, according to the preliminary list of IPO additions to the Russell indexes.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Society Pass surged nearly 70% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSociety Pass surged nearly 70% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-20 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Society Pass&nbsp;surged&nbsp;nearly&nbsp;70%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/72c0eec298020d16e124a5d7b04f0b58\" tg-width=\"716\" tg-height=\"615\" width=\"100%\" height=\"auto\"> Society Pass Incorporated, a leading Southeast Asian data-driven loyalty platform, today announced that the Company will be added to the Russell 2000® Index, effective at the open of the U.S. markets on December 20, 2021, according to the preliminary list of IPO additions to the Russell indexes.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOPA":"Society Pass Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150927570","content_text":"Society Pass surged nearly 70% in premarket trading.\n Society Pass Incorporated, a leading Southeast Asian data-driven loyalty platform, today announced that the Company will be added to the Russell 2000® Index, effective at the open of the U.S. markets on December 20, 2021, according to the preliminary list of IPO additions to the Russell indexes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":943,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693805026,"gmtCreate":1639994340064,"gmtModify":1639994618768,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693805026","repostId":"1100813350","repostType":4,"repost":{"id":"1100813350","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639993227,"share":"https://www.laohu8.com/m/news/1100813350?lang=&edition=full","pubTime":"2021-12-20 17:40","market":"us","language":"en","title":"Novavax shares rose more than 8% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1100813350","media":"Tiger Newspress","summary":"Novavax shares rose more than 8% in premarket trading.The stock rose 11.49% on last Friday as the WH","content":"<p>Novavax&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/41122ce5efa068fd13d80b295b66e434\" tg-width=\"711\" tg-height=\"598\" width=\"100%\" height=\"auto\">The&nbsp;stock&nbsp;rose&nbsp;11.49%&nbsp;on&nbsp;last&nbsp;Friday&nbsp;as&nbsp;the WHO&nbsp;granted emergency authorization to a Covid-19 vaccine produced by Maryland-based Novavax and the Serum Institute of India.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares rose more than 8% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares rose more than 8% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-20 17:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/41122ce5efa068fd13d80b295b66e434\" tg-width=\"711\" tg-height=\"598\" width=\"100%\" height=\"auto\">The&nbsp;stock&nbsp;rose&nbsp;11.49%&nbsp;on&nbsp;last&nbsp;Friday&nbsp;as&nbsp;the WHO&nbsp;granted emergency authorization to a Covid-19 vaccine produced by Maryland-based Novavax and the Serum Institute of India.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100813350","content_text":"Novavax shares rose more than 8% in premarket trading.The stock rose 11.49% on last Friday as the WHO granted emergency authorization to a Covid-19 vaccine produced by Maryland-based Novavax and the Serum Institute of India.","news_type":1},"isVote":1,"tweetType":1,"viewCount":931,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693802815,"gmtCreate":1639994289138,"gmtModify":1639994617139,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693802815","repostId":"1130704419","repostType":4,"repost":{"id":"1130704419","pubTimestamp":1639953553,"share":"https://www.laohu8.com/m/news/1130704419?lang=&edition=full","pubTime":"2021-12-20 06:39","market":"us","language":"en","title":"Nike, Micron, BlackBerry, CarMax, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1130704419","media":"Barrons","summary":"Stock and bond markets around the world will be closed Friday in observance of Christmas. Before the holiday break,Nike and Micron Technology report on Monday,BlackBerry and General Mills on Tuesday, and CarMax,Cintas,and Paychex on Wednesday.It will be a busy week of economic data releases. On Monday, the Conference Board publishes its Leading Economic Index for November, followed by its Consumer Confidence Index for December on Wednesday.On Thursday, the Bureau of Economic Analysis reports per","content":"<p>Stock and bond markets around the world will be closed Friday in observance of Christmas. Before the holiday&nbsp;break,Nike&nbsp;and&nbsp;Micron Technology&nbsp;report on Monday,BlackBerry&nbsp;and&nbsp;General Mills&nbsp;on Tuesday, and&nbsp;CarMax,Cintas,and&nbsp;Paychex&nbsp;on Wednesday.</p>\n<p>It will be a busy week of economic data releases. On Monday, the&nbsp;Conference Board publishes its Leading Economic Index for November, followed&nbsp;by its Consumer Confidence Index for December on Wednesday.</p>\n<p>On Thursday, the&nbsp;Bureau of Economic Analysis reports personal income and consumption expenditures for November. Consumer earnings are forecast to have risen 0.6% while spending is seen climbing 0.5%. The Federal Reserve’s preferred measure of inflation, the core&nbsp;PCE price index, is expected to have spiked 4.5% in November.</p>\n<p>Also Thursday, the Census Bureau releases the durable goods report for November, which will provide a window into investment spending in the economy. New orders are forecast to have risen 2.1%. Housing-market indicators out this week include existing-home sales for November on Wednesday and new-home sales for November on Thursday.</p>\n<p><b>Monday 12/20</b></p>\n<p>Micron Technology and Nike report quarterly results.</p>\n<p><b>The Conference Board</b> releases its Leading Economic Index for November. Consensus estimate is for a 119 reading, which would be 0.6% more than October’s level. The Conference Board currently projects a 5% growth rate for fourth-quarter gross domestic product and a slower but still robust 2.6% for 2022.</p>\n<p><b>Tuesday 12/21</b></p>\n<p>BlackBerry,FactSet Research Systems,and General Mills announce earnings.</p>\n<p><b>Wednesday 12/22</b></p>\n<p><b>The NAR reports</b> existing-home sales for November. Economists forecast a seasonally adjusted annual rate of 6.4 million homes sold, slightly more than in October and the highest since the beginning of the year.</p>\n<p>CarMax, Cintas, and Paychex hold conference calls to discuss quarterly results.</p>\n<p><b>The Bureau of Economic</b> Analysis reports its third and final estimate for third-quarter GDP. Economists forecast a 2.1% seasonally adjusted annual growth rate, unchanged from November’s second estimate.</p>\n<p><b>The Conference Board</b> releases its Consumer Confidence Index for December. Expectations are for a 110 reading, roughly even with the November data. The index is 15% lower than the postpandemic peak reached in June of this year, due to concerns about rising prices and, to a lesser degree, Covid-19 variants.</p>\n<p><b>Thursday 12/23</b></p>\n<p><b>The Department of Labor</b> reports initial jobless claims for the week ending on Dec. 18. Jobless claims have averaged 225,667 a week in November and December, and have finally reached prepandemic levels.</p>\n<p><b>The Census Bureau</b> reports new-home sales for November. Consensus estimate is for a seasonally adjusted annual rate of 770,000 new single-family houses sold, 25,000 more than in October. The median sales price of new houses sold in October was $407,700, while the average sales price was $477,800—both record highs.</p>\n<p><b>The BEA reports</b> personal income and consumption expenditures for November. Economists forecast a 0.6% monthly increase for income and 0.5% for consumption. This compares with gains for 0.5% and 1.3%, respectively, in October. The Federal Reserve’s preferred inflation gauge, the core PCE price index, jumped 4.1% year over year in October, the fastest rate since 1991. Predictions are for it to spike 4.6% in November.</p>\n<p><b>The Census Bureau</b> releases the durable goods report for November. New orders for durable manufactured goods are expected to increase 2.1%, to $265.6 billion. Excluding transportation, new orders are seen gaining 0.6%, compared with a 0.5% rise in October.</p>\n<p><b>Friday 12/24</b></p>\n<p><b>U.S. equity</b>&nbsp;and fixed-income markets are closed in observance of Christmas.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nike, Micron, BlackBerry, CarMax, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNike, Micron, BlackBerry, CarMax, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 06:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/nike-micron-blackberry-carmax-and-other-stocks-for-investors-to-watch-this-week-51639944183?mod=hp_LEAD_5><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stock and bond markets around the world will be closed Friday in observance of Christmas. Before the holiday break,Nike and Micron Technology report on Monday,BlackBerry and General Mills on Tuesday, ...</p>\n\n<a href=\"https://www.barrons.com/articles/nike-micron-blackberry-carmax-and-other-stocks-for-investors-to-watch-this-week-51639944183?mod=hp_LEAD_5\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","KMX":"车美仕",".IXIC":"NASDAQ Composite","MU":"美光科技","CTAS":"信达思",".SPX":"S&P 500 Index","PAYX":"沛齐","GIS":"通用磨坊"},"source_url":"https://www.barrons.com/articles/nike-micron-blackberry-carmax-and-other-stocks-for-investors-to-watch-this-week-51639944183?mod=hp_LEAD_5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130704419","content_text":"Stock and bond markets around the world will be closed Friday in observance of Christmas. Before the holiday break,Nike and Micron Technology report on Monday,BlackBerry and General Mills on Tuesday, and CarMax,Cintas,and Paychex on Wednesday.\nIt will be a busy week of economic data releases. On Monday, the Conference Board publishes its Leading Economic Index for November, followed by its Consumer Confidence Index for December on Wednesday.\nOn Thursday, the Bureau of Economic Analysis reports personal income and consumption expenditures for November. Consumer earnings are forecast to have risen 0.6% while spending is seen climbing 0.5%. The Federal Reserve’s preferred measure of inflation, the core PCE price index, is expected to have spiked 4.5% in November.\nAlso Thursday, the Census Bureau releases the durable goods report for November, which will provide a window into investment spending in the economy. New orders are forecast to have risen 2.1%. Housing-market indicators out this week include existing-home sales for November on Wednesday and new-home sales for November on Thursday.\nMonday 12/20\nMicron Technology and Nike report quarterly results.\nThe Conference Board releases its Leading Economic Index for November. Consensus estimate is for a 119 reading, which would be 0.6% more than October’s level. The Conference Board currently projects a 5% growth rate for fourth-quarter gross domestic product and a slower but still robust 2.6% for 2022.\nTuesday 12/21\nBlackBerry,FactSet Research Systems,and General Mills announce earnings.\nWednesday 12/22\nThe NAR reports existing-home sales for November. Economists forecast a seasonally adjusted annual rate of 6.4 million homes sold, slightly more than in October and the highest since the beginning of the year.\nCarMax, Cintas, and Paychex hold conference calls to discuss quarterly results.\nThe Bureau of Economic Analysis reports its third and final estimate for third-quarter GDP. Economists forecast a 2.1% seasonally adjusted annual growth rate, unchanged from November’s second estimate.\nThe Conference Board releases its Consumer Confidence Index for December. Expectations are for a 110 reading, roughly even with the November data. The index is 15% lower than the postpandemic peak reached in June of this year, due to concerns about rising prices and, to a lesser degree, Covid-19 variants.\nThursday 12/23\nThe Department of Labor reports initial jobless claims for the week ending on Dec. 18. Jobless claims have averaged 225,667 a week in November and December, and have finally reached prepandemic levels.\nThe Census Bureau reports new-home sales for November. Consensus estimate is for a seasonally adjusted annual rate of 770,000 new single-family houses sold, 25,000 more than in October. The median sales price of new houses sold in October was $407,700, while the average sales price was $477,800—both record highs.\nThe BEA reports personal income and consumption expenditures for November. Economists forecast a 0.6% monthly increase for income and 0.5% for consumption. This compares with gains for 0.5% and 1.3%, respectively, in October. The Federal Reserve’s preferred inflation gauge, the core PCE price index, jumped 4.1% year over year in October, the fastest rate since 1991. Predictions are for it to spike 4.6% in November.\nThe Census Bureau releases the durable goods report for November. New orders for durable manufactured goods are expected to increase 2.1%, to $265.6 billion. Excluding transportation, new orders are seen gaining 0.6%, compared with a 0.5% rise in October.\nFriday 12/24\nU.S. equity and fixed-income markets are closed in observance of Christmas.","news_type":1},"isVote":1,"tweetType":1,"viewCount":738,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699280174,"gmtCreate":1639809341186,"gmtModify":1639809341368,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699280174","repostId":"1113440959","repostType":4,"repost":{"id":"1113440959","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752802,"share":"https://www.laohu8.com/m/news/1113440959?lang=&edition=full","pubTime":"2021-12-17 22:53","market":"us","language":"en","title":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113440959","media":"Tiger Newspress","summary":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown","content":"<p>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown&nbsp;Motors&nbsp;sliding&nbsp;6%&nbsp;and General Motors sliding 5%.<img src=\"https://static.tigerbbs.com/cd629a366b9a963976bc2a56e7c34763\" tg-width=\"282\" tg-height=\"468\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7% and General Motors sliding 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown&nbsp;Motors&nbsp;sliding&nbsp;6%&nbsp;and General Motors sliding 5%.<img src=\"https://static.tigerbbs.com/cd629a366b9a963976bc2a56e7c34763\" tg-width=\"282\" tg-height=\"468\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc","GM":"通用汽车","RIVN":"Rivian Automotive, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113440959","content_text":"EV stocks fell sharply in morning trading ,with Rivian sliding 12%,Lucid Group sliding 7%, Lordstown Motors sliding 6% and General Motors sliding 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":758,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699280990,"gmtCreate":1639809327519,"gmtModify":1639809327665,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699280990","repostId":"1109831591","repostType":4,"repost":{"id":"1109831591","pubTimestamp":1639804463,"share":"https://www.laohu8.com/m/news/1109831591?lang=&edition=full","pubTime":"2021-12-18 13:14","market":"us","language":"en","title":"Why Pfizer and Johnson & Johnson Fell on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1109831591","media":"Motley Fool","summary":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnso","content":"<p>What happened</p>\n<p>Two prominent U.S. coronavirus stocks ended the week on a down note.&nbsp;<a href=\"https://laohu8.com/S/PFE\"><b>Pfizer</b></a>&nbsp;and&nbsp;<a href=\"https://laohu8.com/S/JNJ\"><b>Johnson &amp; Johnson</b></a>&nbsp;both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.</p>\n<p><img src=\"https://static.tigerbbs.com/c6a2f152eebbe10f5ab65a99815f461c\" tg-width=\"975\" tg-height=\"637\" width=\"100%\" height=\"auto\"></p>\n<p>So what</p>\n<p><b>Goldman Sachs</b>&nbsp;analyst Chris Shibutani initiated coverage on Pfizer and Johnson &amp; Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.</p>\n<p>Shibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech&nbsp;<b>BioNTech</b>.</p>\n<p>\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.</p>\n<p>As for Johnson &amp; Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.</p>\n<p>\"With [Johnson &amp; Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson &amp; Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.</p>\n<p>Last month, Johnson &amp; Johnson announced plans to spin off its sprawlingconsumer healthcare division.</p>\n<p>Shibutani's price target on Pfizer stock is $51 per share, and that for Johnson &amp; Johnson is $161.</p>\n<p>Now what</p>\n<p>Pfizer and Johnson &amp; Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer and Johnson & Johnson Fell on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer and Johnson & Johnson Fell on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 13:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109831591","content_text":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.\n\nSo what\nGoldman Sachs analyst Chris Shibutani initiated coverage on Pfizer and Johnson & Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.\nShibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech BioNTech.\n\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.\nAs for Johnson & Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.\n\"With [Johnson & Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson & Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.\nLast month, Johnson & Johnson announced plans to spin off its sprawlingconsumer healthcare division.\nShibutani's price target on Pfizer stock is $51 per share, and that for Johnson & Johnson is $161.\nNow what\nPfizer and Johnson & Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.","news_type":1},"isVote":1,"tweetType":1,"viewCount":911,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699217491,"gmtCreate":1639809192669,"gmtModify":1639809192822,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699217491","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p>\n<p>The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":990,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690037324,"gmtCreate":1639612924401,"gmtModify":1639612924545,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690037324","repostId":"2191994955","repostType":4,"repost":{"id":"2191994955","weMediaInfo":{"introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"media_name":"GlobeNewswire","id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"pubTimestamp":1639611885,"share":"https://www.laohu8.com/m/news/2191994955?lang=&edition=full","pubTime":"2021-12-16 07:44","market":"hk","language":"en","title":"Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum","url":"https://stock-news.laohu8.com/highlight/detail?id=2191994955","media":"GlobeNewswire","summary":"Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developi","content":"<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p></p>\n<p>“We are pleased that the FDA has accepted our NDA resubmission for VP-102,” said Ted White, Verrica’s President and Chief Executive Officer. “While we recognize the demands of the Agency’s current workload, we intend to work with the FDA toward approval as quickly as possible based on the limited changes in our resubmission. We continue to be encouraged by the overwhelming demand from both caregivers and the medical community for an FDA-approved treatment for molluscum, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the largest unmet needs in medical dermatology.”</p>\n<p><b>About VP-102</b></p>\n<p>Verrica’s lead product candidate,&nbsp;VP-102,&nbsp;is a proprietary drug-device combination product that contains a&nbsp;GMP-controlled&nbsp;formulation of cantharidin (0.7% w/v) delivered via a&nbsp;single-use&nbsp;applicator that allows for precise topical dosing and targeted administration.&nbsp;If approved, VP-102 would be the first product approved by the FDA to treat molluscum contagiosum — a common, highly contagious skin disease that affects an estimated six million people in the United States, primarily children. VP-102&nbsp;would be marketed in the United States under the conditionally accepted brand name YCANTH™. In addition, Verrica has successfully completed a Phase 2 study of&nbsp;VP-102&nbsp;for the treatment of common warts and a Phase 2 study of&nbsp;VP-102&nbsp;for the treatment of external genital warts.</p>\n<p><b>About Molluscum Contagiosum (Molluscum)</b></p>\n<p>There are currently no&nbsp;FDA-approved&nbsp;treatments for molluscum, a highly contagious viral skin disease that affects approximately six million people — primarily children — in the United States. Molluscum is caused by a pox virus that produces distinctive raised,&nbsp;skin-toned-to-pink-colored&nbsp;lesions that can cause pain, inflammation, itching and bacterial infection. It is easily transmitted through direct&nbsp;skin-to-skin&nbsp;contact or through fomites (objects that carry the disease like toys, towels or wet surfaces) and can spread to other parts of the body or to other people, including siblings. The lesions can be found on most areas of the body and may carry substantial social stigma. Without treatment, molluscum can last for an average of 13 months, and in some cases, up to several years.</p>\n<p><b>About Verrica Pharmaceuticals Inc.</b></p>\n<p>Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica’s late-stage product candidate,&nbsp;VP-102,&nbsp;is in development to treat molluscum, common warts and external genital warts, three of the largest unmet needs in medical dermatology. Verrica is also developing&nbsp;VP-103,&nbsp;its second cantharidin-based product candidate, for the treatment of plantar warts. The Company has also entered a worldwide license agreement with Lytix Biopharma AS to develop and commercialize&nbsp;LTX-315&nbsp;for dermatologic oncology conditions. For more information, visit&nbsp;www.verrica.com.</p>\n<p><b>Forward-Looking Statements</b></p>\n<p>Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “believe,” “expect,” “may,” “plan,” “potential,” “will,” and similar expressions, and are based on Verrica’s current beliefs and expectations. These forward-looking statements include expectations regarding the potential timing and approval of the NDA for&nbsp;VP-102 [and interactions with the FDA]. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Risks and uncertainties that may cause actual results to differ materially include uncertainties inherent in the drug development process and the regulatory approval process, Verrica’s reliance on third parties over which it may not always have full control, uncertainties related to the&nbsp;COVID-19&nbsp;pandemic and other risks and uncertainties that are described in Verrica’s Annual Report on Form&nbsp;10-K&nbsp;for the year ended&nbsp;December 31, 2020 and other filings Verrica makes with the&nbsp;U.S. Securities and Exchange Commission. Any forward-looking statements speak only as of the date of this press release and are based on information available to Verrica as of the date of this release, and Verrica assumes no obligation to, and does not intend to, update any forward-looking statements, whether as a result of new information, future events or otherwise.<img src=\"https://static.tigerbbs.com/c2196de8ba412c60c22ab491af7b1409\" tg-width=\"1\" tg-height=\"1\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVerrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2021-12-16 07:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.</p>\n<p></p>\n<p>“We are pleased that the FDA has accepted our NDA resubmission for VP-102,” said Ted White, Verrica’s President and Chief Executive Officer. “While we recognize the demands of the Agency’s current workload, we intend to work with the FDA toward approval as quickly as possible based on the limited changes in our resubmission. We continue to be encouraged by the overwhelming demand from both caregivers and the medical community for an FDA-approved treatment for molluscum, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the largest unmet needs in medical dermatology.”</p>\n<p><b>About VP-102</b></p>\n<p>Verrica’s lead product candidate,&nbsp;VP-102,&nbsp;is a proprietary drug-device combination product that contains a&nbsp;GMP-controlled&nbsp;formulation of cantharidin (0.7% w/v) delivered via a&nbsp;single-use&nbsp;applicator that allows for precise topical dosing and targeted administration.&nbsp;If approved, VP-102 would be the first product approved by the FDA to treat molluscum contagiosum — a common, highly contagious skin disease that affects an estimated six million people in the United States, primarily children. VP-102&nbsp;would be marketed in the United States under the conditionally accepted brand name YCANTH™. In addition, Verrica has successfully completed a Phase 2 study of&nbsp;VP-102&nbsp;for the treatment of common warts and a Phase 2 study of&nbsp;VP-102&nbsp;for the treatment of external genital warts.</p>\n<p><b>About Molluscum Contagiosum (Molluscum)</b></p>\n<p>There are currently no&nbsp;FDA-approved&nbsp;treatments for molluscum, a highly contagious viral skin disease that affects approximately six million people — primarily children — in the United States. Molluscum is caused by a pox virus that produces distinctive raised,&nbsp;skin-toned-to-pink-colored&nbsp;lesions that can cause pain, inflammation, itching and bacterial infection. It is easily transmitted through direct&nbsp;skin-to-skin&nbsp;contact or through fomites (objects that carry the disease like toys, towels or wet surfaces) and can spread to other parts of the body or to other people, including siblings. The lesions can be found on most areas of the body and may carry substantial social stigma. Without treatment, molluscum can last for an average of 13 months, and in some cases, up to several years.</p>\n<p><b>About Verrica Pharmaceuticals Inc.</b></p>\n<p>Verrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica’s late-stage product candidate,&nbsp;VP-102,&nbsp;is in development to treat molluscum, common warts and external genital warts, three of the largest unmet needs in medical dermatology. Verrica is also developing&nbsp;VP-103,&nbsp;its second cantharidin-based product candidate, for the treatment of plantar warts. The Company has also entered a worldwide license agreement with Lytix Biopharma AS to develop and commercialize&nbsp;LTX-315&nbsp;for dermatologic oncology conditions. For more information, visit&nbsp;www.verrica.com.</p>\n<p><b>Forward-Looking Statements</b></p>\n<p>Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “believe,” “expect,” “may,” “plan,” “potential,” “will,” and similar expressions, and are based on Verrica’s current beliefs and expectations. These forward-looking statements include expectations regarding the potential timing and approval of the NDA for&nbsp;VP-102 [and interactions with the FDA]. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Risks and uncertainties that may cause actual results to differ materially include uncertainties inherent in the drug development process and the regulatory approval process, Verrica’s reliance on third parties over which it may not always have full control, uncertainties related to the&nbsp;COVID-19&nbsp;pandemic and other risks and uncertainties that are described in Verrica’s Annual Report on Form&nbsp;10-K&nbsp;for the year ended&nbsp;December 31, 2020 and other filings Verrica makes with the&nbsp;U.S. Securities and Exchange Commission. Any forward-looking statements speak only as of the date of this press release and are based on information available to Verrica as of the date of this release, and Verrica assumes no obligation to, and does not intend to, update any forward-looking statements, whether as a result of new information, future events or otherwise.<img src=\"https://static.tigerbbs.com/c2196de8ba412c60c22ab491af7b1409\" tg-width=\"1\" tg-height=\"1\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191994955","content_text":"Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the U.S. Food and Drug Administration (FDA) acknowledged that Verrica’s resubmitted New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) was complete and assigned a Prescription Drug User Fee Act (PDUFA) goal date of May 24, 2022.\n\n“We are pleased that the FDA has accepted our NDA resubmission for VP-102,” said Ted White, Verrica’s President and Chief Executive Officer. “While we recognize the demands of the Agency’s current workload, we intend to work with the FDA toward approval as quickly as possible based on the limited changes in our resubmission. We continue to be encouraged by the overwhelming demand from both caregivers and the medical community for an FDA-approved treatment for molluscum, one of the largest unmet needs in medical dermatology.”\nAbout VP-102\nVerrica’s lead product candidate, VP-102, is a proprietary drug-device combination product that contains a GMP-controlled formulation of cantharidin (0.7% w/v) delivered via a single-use applicator that allows for precise topical dosing and targeted administration. If approved, VP-102 would be the first product approved by the FDA to treat molluscum contagiosum — a common, highly contagious skin disease that affects an estimated six million people in the United States, primarily children. VP-102 would be marketed in the United States under the conditionally accepted brand name YCANTH™. In addition, Verrica has successfully completed a Phase 2 study of VP-102 for the treatment of common warts and a Phase 2 study of VP-102 for the treatment of external genital warts.\nAbout Molluscum Contagiosum (Molluscum)\nThere are currently no FDA-approved treatments for molluscum, a highly contagious viral skin disease that affects approximately six million people — primarily children — in the United States. Molluscum is caused by a pox virus that produces distinctive raised, skin-toned-to-pink-colored lesions that can cause pain, inflammation, itching and bacterial infection. It is easily transmitted through direct skin-to-skin contact or through fomites (objects that carry the disease like toys, towels or wet surfaces) and can spread to other parts of the body or to other people, including siblings. The lesions can be found on most areas of the body and may carry substantial social stigma. Without treatment, molluscum can last for an average of 13 months, and in some cases, up to several years.\nAbout Verrica Pharmaceuticals Inc.\nVerrica is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. Verrica’s late-stage product candidate, VP-102, is in development to treat molluscum, common warts and external genital warts, three of the largest unmet needs in medical dermatology. Verrica is also developing VP-103, its second cantharidin-based product candidate, for the treatment of plantar warts. The Company has also entered a worldwide license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatologic oncology conditions. For more information, visit www.verrica.com.\nForward-Looking Statements\nAny statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “believe,” “expect,” “may,” “plan,” “potential,” “will,” and similar expressions, and are based on Verrica’s current beliefs and expectations. These forward-looking statements include expectations regarding the potential timing and approval of the NDA for VP-102 [and interactions with the FDA]. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Risks and uncertainties that may cause actual results to differ materially include uncertainties inherent in the drug development process and the regulatory approval process, Verrica’s reliance on third parties over which it may not always have full control, uncertainties related to the COVID-19 pandemic and other risks and uncertainties that are described in Verrica’s Annual Report on Form 10-K for the year ended December 31, 2020 and other filings Verrica makes with the U.S. Securities and Exchange Commission. Any forward-looking statements speak only as of the date of this press release and are based on information available to Verrica as of the date of this release, and Verrica assumes no obligation to, and does not intend to, update any forward-looking statements, whether as a result of new information, future events or otherwise.","news_type":1},"isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690034624,"gmtCreate":1639612881664,"gmtModify":1639612881802,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Buy?","listText":"Buy?","text":"Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690034624","repostId":"1169241179","repostType":4,"repost":{"id":"1169241179","pubTimestamp":1639611934,"share":"https://www.laohu8.com/m/news/1169241179?lang=&edition=full","pubTime":"2021-12-16 07:45","market":"us","language":"en","title":"Roku Stock Tumbled. Some See a Buying Opportunity.","url":"https://stock-news.laohu8.com/highlight/detail?id=1169241179","media":"Barrons","summary":"Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its","content":"<p>Roku&nbsp;stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with&nbsp;Universal Electronics,and an analyst price-target cut. Some bullish analysts downplayed the patent announcement, calling the drop a buying opportunity in the maker of streaming devices.</p>\n<p>Roku (ticker: ROKU) stock fell 7.9% to close at $203.94 on Wednesday, its lowest close since $203.49 on Nov. 3, 2020. The stock is down 58% from July 26, when shares closed at a record $479.50. The Wednesday drop came as remarks from the Fed sent the tech-heavy&nbsp;Nasdaq Composite index&nbsp;up more than 2%, and the&nbsp;S&amp;P 500 index&nbsp;up 1.6%.</p>\n<p>Investors were caught off guard Wednesday by an announcement by Universal Electronics (UEIC), referring to the public release of the International Trade Commission’s decision in a patent-infringement case, related to technology in certain Roku remote controls. The case was decided in November.</p>\n<p>“We brought this action to protect our highly innovative intellectual property from unauthorized use by Roku, and we are gratified that the ITC recognized Roku’s infringement and ordered it halted,” Universal Electronics said in the news release.</p>\n<p>Roku said in a statement that there were no new developments in the case. “Based on the ITC’s ruling, we do not anticipate any disruption in&nbsp;Roku’s ability to continue to import products,” Roku said.</p>\n<p>Oppenheimer analyst Jason Helfstein noted that the news release may have weighed on Roku stock. He called the dip a buying opportunity, pointing to his bullish outlook for connected-television advertising spending. Helfstein rates Roku stock at Outperform with a $400 price target.</p>\n<p>Aside from selling streaming devices, the company makes the lion’s share of its sales from certain advertisements and subscriptions made on its platform. Shares have fallen in recent months amid lower expectations for growth as the pandemic’s reopening unfolds.</p>\n<p>Also on Wednesday, Morgan Stanley analyst Benjamin Swinburne, who has an Underweight rating on Roku stock, slashed his price target to $190 from $295. He does acknowledge that the stock’s risk-reward setup is less skewed toward risk following recent declines in the share price.</p>\n<p>“We believe the market is underestimating the competition on Platform active accounts in the U.S., as well as the time it takes for international expansion to scale,” Swinburne wrote. “Active account growth has benefited strongly in the U.S. from share gains at TCL, and sustained growth will require additional share gains or major new smart TV partners.”</p>\n<p>Other analysts were more upbeat. Benchmark analyst Daniel Kurnos called the stock’s reaction overstated in a Wednesday note. He has a $525 target with a Buy rating on the stock.</p>\n<p>J.P.Morgan analyst Doug Anmuth called Roku the leading streaming platform in the U.S. by hours streamed, though he did cut his target to $315 from $435.</p>\n<p>“Our bull thesis is largely driven by what we believe to be Roku’s significant advertising opportunity, with streaming accounting for about 42% of TV viewing time for 18-49 year olds in the U.S., but only an estimated about 15% of TV ad budgets,” he wrote.</p>\n<p>He expects outsize growth in Roku’s advertisements business to drive revenue growth north of 25% year over year through 2024, with profitability improving as the platform segment stabilizes and grows as a percentage of revenue. Anmuth rates Roku stock at Outperform.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku Stock Tumbled. Some See a Buying Opportunity.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku Stock Tumbled. Some See a Buying Opportunity.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with Universal Electronics,and an analyst price-target cut. Some bullish analysts ...</p>\n\n<a href=\"https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ROKU":"Roku Inc"},"source_url":"https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169241179","content_text":"Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with Universal Electronics,and an analyst price-target cut. Some bullish analysts downplayed the patent announcement, calling the drop a buying opportunity in the maker of streaming devices.\nRoku (ticker: ROKU) stock fell 7.9% to close at $203.94 on Wednesday, its lowest close since $203.49 on Nov. 3, 2020. The stock is down 58% from July 26, when shares closed at a record $479.50. The Wednesday drop came as remarks from the Fed sent the tech-heavy Nasdaq Composite index up more than 2%, and the S&P 500 index up 1.6%.\nInvestors were caught off guard Wednesday by an announcement by Universal Electronics (UEIC), referring to the public release of the International Trade Commission’s decision in a patent-infringement case, related to technology in certain Roku remote controls. The case was decided in November.\n“We brought this action to protect our highly innovative intellectual property from unauthorized use by Roku, and we are gratified that the ITC recognized Roku’s infringement and ordered it halted,” Universal Electronics said in the news release.\nRoku said in a statement that there were no new developments in the case. “Based on the ITC’s ruling, we do not anticipate any disruption in Roku’s ability to continue to import products,” Roku said.\nOppenheimer analyst Jason Helfstein noted that the news release may have weighed on Roku stock. He called the dip a buying opportunity, pointing to his bullish outlook for connected-television advertising spending. Helfstein rates Roku stock at Outperform with a $400 price target.\nAside from selling streaming devices, the company makes the lion’s share of its sales from certain advertisements and subscriptions made on its platform. Shares have fallen in recent months amid lower expectations for growth as the pandemic’s reopening unfolds.\nAlso on Wednesday, Morgan Stanley analyst Benjamin Swinburne, who has an Underweight rating on Roku stock, slashed his price target to $190 from $295. He does acknowledge that the stock’s risk-reward setup is less skewed toward risk following recent declines in the share price.\n“We believe the market is underestimating the competition on Platform active accounts in the U.S., as well as the time it takes for international expansion to scale,” Swinburne wrote. “Active account growth has benefited strongly in the U.S. from share gains at TCL, and sustained growth will require additional share gains or major new smart TV partners.”\nOther analysts were more upbeat. Benchmark analyst Daniel Kurnos called the stock’s reaction overstated in a Wednesday note. He has a $525 target with a Buy rating on the stock.\nJ.P.Morgan analyst Doug Anmuth called Roku the leading streaming platform in the U.S. by hours streamed, though he did cut his target to $315 from $435.\n“Our bull thesis is largely driven by what we believe to be Roku’s significant advertising opportunity, with streaming accounting for about 42% of TV viewing time for 18-49 year olds in the U.S., but only an estimated about 15% of TV ad budgets,” he wrote.\nHe expects outsize growth in Roku’s advertisements business to drive revenue growth north of 25% year over year through 2024, with profitability improving as the platform segment stabilizes and grows as a percentage of revenue. Anmuth rates Roku stock at Outperform.","news_type":1},"isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690035279,"gmtCreate":1639612838631,"gmtModify":1639612838805,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690035279","repostId":"2191994940","repostType":4,"repost":{"id":"2191994940","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639608624,"share":"https://www.laohu8.com/m/news/2191994940?lang=&edition=full","pubTime":"2021-12-16 06:50","market":"us","language":"en","title":"Wall St ends higher; Fed to end bond purchases in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2191994940","media":"Reuters","summary":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow ","content":"<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends higher; Fed to end bond purchases in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends higher; Fed to end bond purchases in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-16 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","AAPL":"苹果",".SPX":"S&P 500 Index","NVDA":"英伟达","ALB":"美国雅保",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191994940","content_text":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow +1.08%, S&P 500 +1.63%, Nasdaq +2.15%\n\nDec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.\nFollowing its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.\nAll three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an upbeat tone about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.\n\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"\nThe S&P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.\nFor the session, the Dow Jones Industrial Average rose 1.08% to end at 35,927.43 points, while the S&P 500 gained 1.63% to 4,709.85.\nThe Nasdaq Composite climbed 2.15% to 15,565.58.\nVolume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.\nInflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.\n\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"\nAmong the 11 S&P 500 sector indexes, technology jumped 2.7% and healthcare rallied 2.1%.\nApple Inc climbed 2.85% and Nvidia Corp rallied 7.49%, with both lifting the S&P 500 more than any other stocks.\nThe Philadelphia Semiconductor index jumped 3.7%.\nAlbemarle Corp ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"\nAdvancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.\nThe S&P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607236868,"gmtCreate":1639543207562,"gmtModify":1639543207724,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Good. Pls like","listText":"Good. Pls like","text":"Good. Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607236868","repostId":"1124672339","repostType":4,"isVote":1,"tweetType":1,"viewCount":313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607236054,"gmtCreate":1639543096544,"gmtModify":1639543096675,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Yes!","listText":"Yes!","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607236054","repostId":"1141838908","repostType":4,"isVote":1,"tweetType":1,"viewCount":414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607238190,"gmtCreate":1639543048119,"gmtModify":1639543048246,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607238190","repostId":"1102037947","repostType":4,"repost":{"id":"1102037947","pubTimestamp":1639539908,"share":"https://www.laohu8.com/m/news/1102037947?lang=&edition=full","pubTime":"2021-12-15 11:45","market":"us","language":"en","title":"What Does The Giphy Deal Block Mean For Meta's Business Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1102037947","media":"Seeking Alpha","summary":"Summary\n\nThe Giphy deal getting blocked brings antitrust issues for Meta Platforms into the spotligh","content":"<p><b>Summary</b></p>\n<ul>\n <li>The Giphy deal getting blocked brings antitrust issues for Meta Platforms into the spotlight; the Federal Trade Commission also wants FB to dispose of its interests in Instagram and WhatsApp.</li>\n <li>I am still positive on Meta's intermediate-term business outlook. The key thing to note is that FB will likely focus more on organic growth rather than mergers or acquisitions.</li>\n <li>I still rate Meta's shares as a Buy, as I don't expect the Giphy deal to have a negative impact on the company's business outlook.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a75257db34dbc79d0928866473753b5c\" tg-width=\"1536\" tg-height=\"1025\" width=\"100%\" height=\"auto\"><span>Fritz Jorgensen/iStock Editorial via Getty Images</span></p>\n<p><b>Elevator Pitch</b></p>\n<p>I retain my Buy rating for Meta Platforms, Inc. (FB). In&nbsp;my previous article&nbsp;for FB published on October 7, 2021, I touched on Meta Platforms' five-year outlook. In this latest article, I focus my attention on the Giphy deal being blocked and discuss how this might potentially affect FB's future growth prospects.</p>\n<p>The Giphy deal brings the market's attention to antitrust issues for FB, and it is noteworthy that Meta Platforms has already shifted its focus to organic growth initiatives prior to this recent regulatory development. The Giphy deal being blocked has not changed my positive views of Meta Platforms' outlook, and I still maintain a Buy investment rating for FB in views of its valuations and growth prospects.</p>\n<p><b>Why Was Meta Ordered To Sell Giphy?</b></p>\n<p><i>Seeking Alpha News</i>&nbsp;reported&nbsp;at the end of last month that Meta Platforms \"was told by the U.K. Competition and Markets Authority that it must sell Giphy, the largest provider of animated images to social networks.\" In the news article, it was stated that the U.K. Competition and Markets Authority made the decision to order FB to sell Giphy on the basis that \"Meta's acquisition of Giphy would reduce competition\" or \"limit other platforms' access to Giphy gifs.\"</p>\n<p>It is possible to draw a parallel between the U.K. Competition and Markets Authority's decision on&nbsp;the Giphy deal, and the Federal Trade Commission's antitrust case with regards to Meta Platforms' prior acquisitions of WhatsApp and Instagram.</p>\n<p>An August 19, 2021&nbsp;<i>Reuters</i>&nbsp;article&nbsp;mentioned&nbsp;that the Federal Trade Commission \"refreshed its antitrust case against\" FB and is \"once again asking a judge to force the social media giant to sell Instagram and WhatsApp.\" In the Federal Trade Commission's&nbsp;official press release&nbsp;published on the same day, it was emphasized that Meta Platforms \"resorted to illegal buy-or-bury scheme to crush competition after a string of failed attempts to innovate.\"</p>\n<p>In other words, it is clear that the UK regulators have blocked Meta Platforms' acquisition of Giphy due to antitrust issues, which is also exactly why FB has been targeted by the Federal Trade Commission for its previous M&amp;A deals. This latest development has a meaningful influence on FB's growth strategies, which I address in the next section of this article.</p>\n<p><b>What Is Meta Platforms' Business Outlook?</b></p>\n<p>I highlighted in my early-October 2021 article that \"I am positive on Facebook's (Meta Platform's former corporate name) growth prospects in the next five years\" and stressed that \"I view the sell-side's expectations of mid-teens earnings growth over this period as reasonable.\"</p>\n<p>My positive view of Meta Platforms' business outlook remains unchanged, but I think that FB has to further optimize its growth strategies in response to the Giphy deal block and antitrust issues in general. Specifically, Meta Platforms has to focus more on organic growth (e.g. product innovation) and be less reliant on inorganic growth (e.g. mergers &amp; acquisitions). The good news is that Meta Platforms has already started to pivot towards organic growth strategies way before the UK regulators' latest decision on Giphy.</p>\n<p>A<i>New York Times</i>&nbsp;article&nbsp;published on August 12, 2019 noted that FB \"halted acquisition talks with Houseparty, a video-focused social network in Silicon Valley, for fear of inciting antitrust concerns.\" Instead of engaging in M&amp;A, Meta Platforms has chosen to pursue new product innovations. Examples of these new organic growth initiatives include&nbsp;Facebook Shops&nbsp;(mobile shopping) and&nbsp;Instagram Reels&nbsp;(short-form videos) which were officially launched in May 2020 and August 2020, respectively. The recent Giphy deal only makes it more likely that Meta Platforms will prioritize organic investments over mergers and acquisitions.</p>\n<p>Separately, the Metaverse is a new growth area that Meta Platforms intends to focus on. In a&nbsp;Founders' Letter&nbsp;published on October 28, 2021, CEO Mark Zuckerberg noted that he hopes that \"the Metaverse will reach a billion people, host hundreds of billions of dollars of digital commerce\" in the next 10 years, and he emphasized that FB \"built our business to support very large and long term investments to build better services\" in that respect. This seems to imply that Meta Platforms is prepared to make significant investments to drive the company's future growth relating to the Metaverse. More importantly, FB's investments related to the Metaverse are likely to be organic in nature, rather than mergers and acquisitions.</p>\n<p>Earlier, Meta Platforms mentioned at the company's&nbsp;Q3 2021 results call&nbsp;that it is \"building multiple generations of our VR and AR products at the same time\", and its other Metaverse-related investments include \"a new operating system and development model, a digital commerce platform, content studios, and of course a social platform.\" FB also guided at the recent quarterly investor briefing that \"these investments (are expected) to reduce our overall operating profit by approximately $10 billion\" in 2021, and should \"grow even further for each of the next several years.\"</p>\n<p>Looking at Meta Platform's historical capital expenditures and its expected capital expenditures in the future (as per sell-side' consensus estimates) tells a similar story. According to S&amp;P Capital IQ data, FB's historical capital expenditures only increased by +8.5% and +0.1% in fiscal 2019 and fiscal 2020, respectively. But market consensus expects Meta Platform's future capital expenditures to grow by +26% and +51% to $19.0 billion and $28.7 billion for FY 2021 and FY 2022, respectively. In addition, sell-side analysts see FB's annual capital expenditures remaining elevated at around the $30 billion mark between fiscal 2023 and 2025. Although it is unclear whether the Wall Street analysts had included any potential mergers and acquisitions as part of their respective capital expenditure forecasts, it will be reasonable to expect that the majority of FB's capital expenditures in the near-to-intermediate term will be organic growth initiatives due to antitrust risks.</p>\n<p>In my October 7, 2021, article, I noted that the company's \"future revenue growth is expected to be supported by the expansion of the digital advertising market, and an increase in price per ad driven by new product features.\" Given the Giphy deal block, I see Meta Platforms continuing to invest heavily in organic growth initiatives. These investments will be supportive of FB's top line and bottom line growth in the mid-teens percentage range (FY 2022 earnings growth is an exception due to the high base in FY 2021) for the next few years as per market consensus' expectations (in the chart below) which I think are realistic.</p>\n<p><b>FB's Consensus Revenue And Earnings Per Share Forecasts</b></p>\n<p><img src=\"https://static.tigerbbs.com/c8715889ccf4ecb3a6dc8e5bfaf0c62a\" tg-width=\"640\" tg-height=\"368\" width=\"100%\" height=\"auto\"></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ad3a3a638a98509b89bec1ac233e5c1f\" tg-width=\"640\" tg-height=\"351\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha's Earnings Estimates Page For Meta Platforms</span></p>\n<p>Lastly, I am not too concerned about the Federal Trade Commission's antitrust case and its impact on Meta Platform's business outlook. Such legal cases tend to be long and drawn out, and it is uncertain if it is in the best interests of consumers that WhatsApp and Instagram either become independent of FB or be acquired by other entities.</p>\n<p><b>Is FB Stock A Buy, Sell, Or Hold?</b></p>\n<p>FB stock is still a Buy.</p>\n<p>The Giphy deal block only implies that Meta Platforms will largely stay away from mergers and acquisitions as a means of growth. Instead, FB is most probably going to allocate more capital to organic investments with the aim of introducing new products and capitalizing on growth opportunities associated with the Metaverse.</p>\n<p>FB is currently valued by the market at consensus forward fiscal 2022 and 2023 P/E multiples of 23.2 times and 19.7 times, respectively. I view Meta Platforms' current valuations as undemanding for a company that can deliver earnings growth in the mid-teens percentage levels and return on assets or ROAs in the high-teens percentage levels (as per S&amp;P Capital IQ's consensus financial forecasts). As such, I continue to assign a Buy rating to Meta Platforms' shares.</p>\n<p>The key risk factors for Meta Platforms include further antitrust investigations relating to the company's past acquisitions, and new organic investments failing to achieve the desired results for the company.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What Does The Giphy Deal Block Mean For Meta's Business Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat Does The Giphy Deal Block Mean For Meta's Business Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 11:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4475242-giphy-deal-block-meta-business-outlook><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe Giphy deal getting blocked brings antitrust issues for Meta Platforms into the spotlight; the Federal Trade Commission also wants FB to dispose of its interests in Instagram and WhatsApp....</p>\n\n<a href=\"https://seekingalpha.com/article/4475242-giphy-deal-block-meta-business-outlook\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/article/4475242-giphy-deal-block-meta-business-outlook","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102037947","content_text":"Summary\n\nThe Giphy deal getting blocked brings antitrust issues for Meta Platforms into the spotlight; the Federal Trade Commission also wants FB to dispose of its interests in Instagram and WhatsApp.\nI am still positive on Meta's intermediate-term business outlook. The key thing to note is that FB will likely focus more on organic growth rather than mergers or acquisitions.\nI still rate Meta's shares as a Buy, as I don't expect the Giphy deal to have a negative impact on the company's business outlook.\n\nFritz Jorgensen/iStock Editorial via Getty Images\nElevator Pitch\nI retain my Buy rating for Meta Platforms, Inc. (FB). In my previous article for FB published on October 7, 2021, I touched on Meta Platforms' five-year outlook. In this latest article, I focus my attention on the Giphy deal being blocked and discuss how this might potentially affect FB's future growth prospects.\nThe Giphy deal brings the market's attention to antitrust issues for FB, and it is noteworthy that Meta Platforms has already shifted its focus to organic growth initiatives prior to this recent regulatory development. The Giphy deal being blocked has not changed my positive views of Meta Platforms' outlook, and I still maintain a Buy investment rating for FB in views of its valuations and growth prospects.\nWhy Was Meta Ordered To Sell Giphy?\nSeeking Alpha News reported at the end of last month that Meta Platforms \"was told by the U.K. Competition and Markets Authority that it must sell Giphy, the largest provider of animated images to social networks.\" In the news article, it was stated that the U.K. Competition and Markets Authority made the decision to order FB to sell Giphy on the basis that \"Meta's acquisition of Giphy would reduce competition\" or \"limit other platforms' access to Giphy gifs.\"\nIt is possible to draw a parallel between the U.K. Competition and Markets Authority's decision on the Giphy deal, and the Federal Trade Commission's antitrust case with regards to Meta Platforms' prior acquisitions of WhatsApp and Instagram.\nAn August 19, 2021 Reuters article mentioned that the Federal Trade Commission \"refreshed its antitrust case against\" FB and is \"once again asking a judge to force the social media giant to sell Instagram and WhatsApp.\" In the Federal Trade Commission's official press release published on the same day, it was emphasized that Meta Platforms \"resorted to illegal buy-or-bury scheme to crush competition after a string of failed attempts to innovate.\"\nIn other words, it is clear that the UK regulators have blocked Meta Platforms' acquisition of Giphy due to antitrust issues, which is also exactly why FB has been targeted by the Federal Trade Commission for its previous M&A deals. This latest development has a meaningful influence on FB's growth strategies, which I address in the next section of this article.\nWhat Is Meta Platforms' Business Outlook?\nI highlighted in my early-October 2021 article that \"I am positive on Facebook's (Meta Platform's former corporate name) growth prospects in the next five years\" and stressed that \"I view the sell-side's expectations of mid-teens earnings growth over this period as reasonable.\"\nMy positive view of Meta Platforms' business outlook remains unchanged, but I think that FB has to further optimize its growth strategies in response to the Giphy deal block and antitrust issues in general. Specifically, Meta Platforms has to focus more on organic growth (e.g. product innovation) and be less reliant on inorganic growth (e.g. mergers & acquisitions). The good news is that Meta Platforms has already started to pivot towards organic growth strategies way before the UK regulators' latest decision on Giphy.\nANew York Times article published on August 12, 2019 noted that FB \"halted acquisition talks with Houseparty, a video-focused social network in Silicon Valley, for fear of inciting antitrust concerns.\" Instead of engaging in M&A, Meta Platforms has chosen to pursue new product innovations. Examples of these new organic growth initiatives include Facebook Shops (mobile shopping) and Instagram Reels (short-form videos) which were officially launched in May 2020 and August 2020, respectively. The recent Giphy deal only makes it more likely that Meta Platforms will prioritize organic investments over mergers and acquisitions.\nSeparately, the Metaverse is a new growth area that Meta Platforms intends to focus on. In a Founders' Letter published on October 28, 2021, CEO Mark Zuckerberg noted that he hopes that \"the Metaverse will reach a billion people, host hundreds of billions of dollars of digital commerce\" in the next 10 years, and he emphasized that FB \"built our business to support very large and long term investments to build better services\" in that respect. This seems to imply that Meta Platforms is prepared to make significant investments to drive the company's future growth relating to the Metaverse. More importantly, FB's investments related to the Metaverse are likely to be organic in nature, rather than mergers and acquisitions.\nEarlier, Meta Platforms mentioned at the company's Q3 2021 results call that it is \"building multiple generations of our VR and AR products at the same time\", and its other Metaverse-related investments include \"a new operating system and development model, a digital commerce platform, content studios, and of course a social platform.\" FB also guided at the recent quarterly investor briefing that \"these investments (are expected) to reduce our overall operating profit by approximately $10 billion\" in 2021, and should \"grow even further for each of the next several years.\"\nLooking at Meta Platform's historical capital expenditures and its expected capital expenditures in the future (as per sell-side' consensus estimates) tells a similar story. According to S&P Capital IQ data, FB's historical capital expenditures only increased by +8.5% and +0.1% in fiscal 2019 and fiscal 2020, respectively. But market consensus expects Meta Platform's future capital expenditures to grow by +26% and +51% to $19.0 billion and $28.7 billion for FY 2021 and FY 2022, respectively. In addition, sell-side analysts see FB's annual capital expenditures remaining elevated at around the $30 billion mark between fiscal 2023 and 2025. Although it is unclear whether the Wall Street analysts had included any potential mergers and acquisitions as part of their respective capital expenditure forecasts, it will be reasonable to expect that the majority of FB's capital expenditures in the near-to-intermediate term will be organic growth initiatives due to antitrust risks.\nIn my October 7, 2021, article, I noted that the company's \"future revenue growth is expected to be supported by the expansion of the digital advertising market, and an increase in price per ad driven by new product features.\" Given the Giphy deal block, I see Meta Platforms continuing to invest heavily in organic growth initiatives. These investments will be supportive of FB's top line and bottom line growth in the mid-teens percentage range (FY 2022 earnings growth is an exception due to the high base in FY 2021) for the next few years as per market consensus' expectations (in the chart below) which I think are realistic.\nFB's Consensus Revenue And Earnings Per Share Forecasts\n\nSource: Seeking Alpha's Earnings Estimates Page For Meta Platforms\nLastly, I am not too concerned about the Federal Trade Commission's antitrust case and its impact on Meta Platform's business outlook. Such legal cases tend to be long and drawn out, and it is uncertain if it is in the best interests of consumers that WhatsApp and Instagram either become independent of FB or be acquired by other entities.\nIs FB Stock A Buy, Sell, Or Hold?\nFB stock is still a Buy.\nThe Giphy deal block only implies that Meta Platforms will largely stay away from mergers and acquisitions as a means of growth. Instead, FB is most probably going to allocate more capital to organic investments with the aim of introducing new products and capitalizing on growth opportunities associated with the Metaverse.\nFB is currently valued by the market at consensus forward fiscal 2022 and 2023 P/E multiples of 23.2 times and 19.7 times, respectively. I view Meta Platforms' current valuations as undemanding for a company that can deliver earnings growth in the mid-teens percentage levels and return on assets or ROAs in the high-teens percentage levels (as per S&P Capital IQ's consensus financial forecasts). As such, I continue to assign a Buy rating to Meta Platforms' shares.\nThe key risk factors for Meta Platforms include further antitrust investigations relating to the company's past acquisitions, and new organic investments failing to achieve the desired results for the company.","news_type":1},"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607231414,"gmtCreate":1639543026343,"gmtModify":1639543026517,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607231414","repostId":"1156446659","repostType":4,"repost":{"id":"1156446659","pubTimestamp":1639540344,"share":"https://www.laohu8.com/m/news/1156446659?lang=&edition=full","pubTime":"2021-12-15 11:52","market":"us","language":"en","title":"Warren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap","url":"https://stock-news.laohu8.com/highlight/detail?id=1156446659","media":"Business Insider","summary":"Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Frid","content":"<ul>\n <li><b>Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.</b></li>\n <li><b>That makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $649 billion market capitalization.</b></li>\n <li><b>Warren Buffett started to build Berkshire's position in Apple in 2016 and added to it up until mid-2018.</b></li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4348b5dc216a2be5e154d22e356336b9\" tg-width=\"790\" tg-height=\"395\" width=\"100%\" height=\"auto\"><span>SCOTT MORGAN/REUTERS</span></p>\n<p>Warren Buffett is known for concentrating his investments to build generational wealth, and&nbsp;Berkshire Hathaway's&nbsp;stake in&nbsp;Apple&nbsp;is no better example of that investment practice.</p>\n<p>Berkshire's 887.1 million shares in the iPhone maker swelled to a record value of $159 billion on Friday, a 342% increase from its&nbsp;original cost basis of about $36 billion.That means Apple is now worth more than half of Berkshire's $293 billion equity portfolio, based on data from its third-quarter 13F filing.</p>\n<p>And assuming Berkshire hasn't trimmed its Apple position since September 30, the equity stake now represents about a quarter of Berkshire Hathaway's $649 billion market capitalization.</p>\n<p>What also makes Buffett's concentration in Apple notable is that it didn't take&nbsp;decades to compound&nbsp;like most successful investments managed by Buffett. Instead, it's only been five years since Berkshire began to build its stake in Apple.</p>\n<p>The conglomerate first purchased Apple shares in 2016 and continued buying them until mid-2018, when the position topped 1 billion shares after adjusting for a 4-for-1 stock split in 2020. Buffett has&nbsp;trimmed Berkshire's position in Apple&nbsp;by about 12% since initially building the stake.</p>\n<p>Barring any changes since the most recent 13F filing, Berkshire's stock portfolio would be up 13.9% quarter-to-date, according to&nbsp;an analysis by Bespoke.Much of that gain has been driven by Apple's quarter-to-date gain of more than 20%.</p>\n<p>Year-to-date, Apple is up 31%, compared to Berkshire Hathaway's return of 26%. Apple's stock price was less than&nbsp;$1.00 away from hitting a $3 trillion valuation on Monday.</p>\n<p>Berkshire's three largest positions after Apple are&nbsp;Bank of America,American Express, and&nbsp;Coca-Cola, which make up a combined 30% of the equity portfolio's value. And Berkshire is still sitting on about $150 billion in cash that it has yet to put to work.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 11:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12><strong>Business Insider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.\nThat makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $...</p>\n\n<a href=\"https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156446659","content_text":"Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.\nThat makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $649 billion market capitalization.\nWarren Buffett started to build Berkshire's position in Apple in 2016 and added to it up until mid-2018.\n\nSCOTT MORGAN/REUTERS\nWarren Buffett is known for concentrating his investments to build generational wealth, and Berkshire Hathaway's stake in Apple is no better example of that investment practice.\nBerkshire's 887.1 million shares in the iPhone maker swelled to a record value of $159 billion on Friday, a 342% increase from its original cost basis of about $36 billion.That means Apple is now worth more than half of Berkshire's $293 billion equity portfolio, based on data from its third-quarter 13F filing.\nAnd assuming Berkshire hasn't trimmed its Apple position since September 30, the equity stake now represents about a quarter of Berkshire Hathaway's $649 billion market capitalization.\nWhat also makes Buffett's concentration in Apple notable is that it didn't take decades to compound like most successful investments managed by Buffett. Instead, it's only been five years since Berkshire began to build its stake in Apple.\nThe conglomerate first purchased Apple shares in 2016 and continued buying them until mid-2018, when the position topped 1 billion shares after adjusting for a 4-for-1 stock split in 2020. Buffett has trimmed Berkshire's position in Apple by about 12% since initially building the stake.\nBarring any changes since the most recent 13F filing, Berkshire's stock portfolio would be up 13.9% quarter-to-date, according to an analysis by Bespoke.Much of that gain has been driven by Apple's quarter-to-date gain of more than 20%.\nYear-to-date, Apple is up 31%, compared to Berkshire Hathaway's return of 26%. Apple's stock price was less than $1.00 away from hitting a $3 trillion valuation on Monday.\nBerkshire's three largest positions after Apple are Bank of America,American Express, and Coca-Cola, which make up a combined 30% of the equity portfolio's value. And Berkshire is still sitting on about $150 billion in cash that it has yet to put to work.","news_type":1},"isVote":1,"tweetType":1,"viewCount":394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607384050,"gmtCreate":1639490474770,"gmtModify":1639490474925,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607384050","repostId":"1160149319","repostType":4,"repost":{"id":"1160149319","pubTimestamp":1639488598,"share":"https://www.laohu8.com/m/news/1160149319?lang=&edition=full","pubTime":"2021-12-14 21:29","market":"us","language":"en","title":"Footprint Agrees to $1.6 Billion Gores SPAC Deal as Koch Invests","url":"https://stock-news.laohu8.com/highlight/detail?id=1160149319","media":"Bloomberg","summary":"Footprint, a materials-science technology company seeking to eliminate single-use plastic, agreed to","content":"<p>Footprint, a materials-science technology company seeking to eliminate single-use plastic, agreed to merge with Gores Holdings VIII Inc., a special purpose acquisition company led by billionaire Alec Gores.</p>\n<p>The transaction is slated to give the combined company an enterprise value of $1.6 billion at its completion assuming there are no redemptions, according to a statement Tuesday confirming an earlier Bloomberg News report. The deal features a roughly $310 million private investment in public equity, or PIPE. The PIPE, priced at $10 a share, was backed by Koch Strategic Platforms among others and Koch separately committed to provide $150 million in preferred financing.</p>\n<p>Gilbert, Arizona-based Footprint’s customers include Kraft Heinz Co., McDonald’s Corp. and Procter &amp; Gamble Co. Increased government regulation, heightened corporate sustainability efforts and changing societal preferences have been a boost to its business, with many consumer-packaged-goods companies seeking alternatives to single-use plastic.</p>\n<p>Footprint’s investors, including Sweetgreen Inc., Conagra Brands Inc. and JBS, will roll 100% of their equity into the new entity and are set to own about 62% of the company.</p>\n<p>The new entity will be led by Footprint co-founder and Chief Executive Officer Troy Swope and be listed with the ticker “FOOT” on the Nasdaq.</p>\n<p>Footprint plans to spend proceeds raised through the transaction on expanding manufacturing capacity through factories in Mexico and Poland, Swope said in an interview. The company, which makes sustainable, plant-based products, is hoping to capitalize on an estimated $315 billion annual market opportunity, he added.</p>\n<p>“This is not a science experiment, and to execute on our revenue projections we don’t need any leaps in innovation -- we just need to continue to execute,” said Swope, adding that Footprint’s packaging helps customers drastically reduce their carbon emissions.</p>\n<p>Footprint expects its revenue to grow to $135 million next year, and $500 million in 2023, from about $50 million this year, he said.</p>\n<p>Bloomberg News reported in August that Footprint was in talks to go public through a deal with a Gores SPAC at a valuation of as much as $3 billion. The transaction was recalibrated in recent months, in part due to feedback from SPAC investors.</p>\n<p>“We want to ensure shareholders are set up for long-term success and exceptional performance” after the deal closes, said Gores Holdings VIII CEO Mark Stone, referring to the refreshed valuation.</p>\n<p>Gores Holdings VIII, led by Gores and Stone, raised $345 million in a February IPO. Other Gores SPACs have merged to form companies including Ardagh Metal Packaging SA and Matterport Inc.</p>\n<p>“The SPAC market is an interesting place to be today,” Gores said in an interview, describing the recent market correction, which has resulted in a flurry of deal terminations, as a “bit of a blessing.”</p>\n<p>Blank-check companies are a “great product as long as they’re not being abused,” said Gores, adding that his affiliated SPACs set their own guardrails, including obtaining fairness opinions from independent advisers for each transaction.</p>\n<p>“We welcome additional disclosures,” Stone said.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Footprint Agrees to $1.6 Billion Gores SPAC Deal as Koch Invests</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFootprint Agrees to $1.6 Billion Gores SPAC Deal as Koch Invests\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/footprint-said-agree-gores-spac-050100964.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Footprint, a materials-science technology company seeking to eliminate single-use plastic, agreed to merge with Gores Holdings VIII Inc., a special purpose acquisition company led by billionaire Alec ...</p>\n\n<a href=\"https://finance.yahoo.com/news/footprint-said-agree-gores-spac-050100964.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GIIXU":"Gores Holdings VIII, Inc."},"source_url":"https://finance.yahoo.com/news/footprint-said-agree-gores-spac-050100964.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160149319","content_text":"Footprint, a materials-science technology company seeking to eliminate single-use plastic, agreed to merge with Gores Holdings VIII Inc., a special purpose acquisition company led by billionaire Alec Gores.\nThe transaction is slated to give the combined company an enterprise value of $1.6 billion at its completion assuming there are no redemptions, according to a statement Tuesday confirming an earlier Bloomberg News report. The deal features a roughly $310 million private investment in public equity, or PIPE. The PIPE, priced at $10 a share, was backed by Koch Strategic Platforms among others and Koch separately committed to provide $150 million in preferred financing.\nGilbert, Arizona-based Footprint’s customers include Kraft Heinz Co., McDonald’s Corp. and Procter & Gamble Co. Increased government regulation, heightened corporate sustainability efforts and changing societal preferences have been a boost to its business, with many consumer-packaged-goods companies seeking alternatives to single-use plastic.\nFootprint’s investors, including Sweetgreen Inc., Conagra Brands Inc. and JBS, will roll 100% of their equity into the new entity and are set to own about 62% of the company.\nThe new entity will be led by Footprint co-founder and Chief Executive Officer Troy Swope and be listed with the ticker “FOOT” on the Nasdaq.\nFootprint plans to spend proceeds raised through the transaction on expanding manufacturing capacity through factories in Mexico and Poland, Swope said in an interview. The company, which makes sustainable, plant-based products, is hoping to capitalize on an estimated $315 billion annual market opportunity, he added.\n“This is not a science experiment, and to execute on our revenue projections we don’t need any leaps in innovation -- we just need to continue to execute,” said Swope, adding that Footprint’s packaging helps customers drastically reduce their carbon emissions.\nFootprint expects its revenue to grow to $135 million next year, and $500 million in 2023, from about $50 million this year, he said.\nBloomberg News reported in August that Footprint was in talks to go public through a deal with a Gores SPAC at a valuation of as much as $3 billion. The transaction was recalibrated in recent months, in part due to feedback from SPAC investors.\n“We want to ensure shareholders are set up for long-term success and exceptional performance” after the deal closes, said Gores Holdings VIII CEO Mark Stone, referring to the refreshed valuation.\nGores Holdings VIII, led by Gores and Stone, raised $345 million in a February IPO. Other Gores SPACs have merged to form companies including Ardagh Metal Packaging SA and Matterport Inc.\n“The SPAC market is an interesting place to be today,” Gores said in an interview, describing the recent market correction, which has resulted in a flurry of deal terminations, as a “bit of a blessing.”\nBlank-check companies are a “great product as long as they’re not being abused,” said Gores, adding that his affiliated SPACs set their own guardrails, including obtaining fairness opinions from independent advisers for each transaction.\n“We welcome additional disclosures,” Stone said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":409,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607385366,"gmtCreate":1639490417552,"gmtModify":1639490417679,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607385366","repostId":"1192557604","repostType":4,"repost":{"id":"1192557604","pubTimestamp":1639488210,"share":"https://www.laohu8.com/m/news/1192557604?lang=&edition=full","pubTime":"2021-12-14 21:23","market":"us","language":"en","title":"4 Stocks Insiders Are Selling","url":"https://stock-news.laohu8.com/highlight/detail?id=1192557604","media":"Benzinga","summary":"Tesla\n\nThe Trade:Tesla, Inc. CEO Elon Musk disposed a total of 169111 shares at an average price of ","content":"<p><b>Tesla</b></p>\n<ul>\n <li><b>The Trade:Tesla, Inc.</b>&nbsp;CEO Elon Musk&nbsp;<i>disposed a total of 169111 shares</i>&nbsp;at an average price of $992.27. The insider received $167,804,267.54 as a result of the transaction.</li>\n <li><b>What’s Happening:</b>Tesla CEO Elon Musk-owned SpaceX has a plan to draw carbon dioxide from the earth’s atmosphere and use it as rocket fuel.</li>\n <li><b>What Tesla Does:</b>Founded in 2003 and based in Palo Alto, California, Tesla is a vertically integrated sustainable energy company that also aims to transition the world to electric mobility by making electric vehicles.</li>\n</ul>\n<p><b>Box</b></p>\n<ul>\n <li><b>The Trade:Box, Inc.</b>&nbsp;Director Daniel Levin<i>sold a total of 128600 shares</i>&nbsp;at an average price of $26.04. The insider received $3,348,245.17 from selling those shares.</li>\n <li><b>What’s Happening:</b>Box recently reported better-than-expected Q3 EPS and sales results.</li>\n <li><b>What Box Does:</b>Box was founded in 2005 as a natively built cloud file sync and sharing provider for enterprises. Box is headquartered in Redwood City, California.</li>\n</ul>\n<p><b>QUALCOMM</b></p>\n<ul>\n <li><b>The Trade:QUALCOMM Incorporated</b>&nbsp;Chief Technology Officer James H Thompson&nbsp;<i>sold a total of 10000 shares</i>&nbsp;at an average price of $183.39. The insider received $1,815,526.35 as a result of the transaction.</li>\n <li><b>What’s Happening:</b>JPMorgan added Qualcomm to the firm's Analyst Focus List.</li>\n <li><b>What QUALCOMM Does:</b>Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks.</li>\n</ul>\n<p><b>Southwest Airlines</b></p>\n<ul>\n <li><b>The Trade:Southwest Airlines Co.</b>&nbsp;Director John T Montford<i>sold a total of 3230 shares</i>&nbsp;at an average price of $43.88. The insider received $23,697.36 from selling those shares.</li>\n <li><b>What’s Happening:</b>Goldman Sachs recently downgraded the stock from Neutral to Sell and lowered its price target from $59 to $36.</li>\n <li><b>What Southwest Airlines Does:</b>Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Insiders Are Selling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Insiders Are Selling\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24589297/4-stocks-insiders-are-selling><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla\n\nThe Trade:Tesla, Inc. CEO Elon Musk disposed a total of 169111 shares at an average price of $992.27. The insider received $167,804,267.54 as a result of the transaction.\nWhat’s Happening:Tesla...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24589297/4-stocks-insiders-are-selling\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","BOX":"Box Inc","QCOM":"高通"},"source_url":"https://www.benzinga.com/news/21/12/24589297/4-stocks-insiders-are-selling","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192557604","content_text":"Tesla\n\nThe Trade:Tesla, Inc. CEO Elon Musk disposed a total of 169111 shares at an average price of $992.27. The insider received $167,804,267.54 as a result of the transaction.\nWhat’s Happening:Tesla CEO Elon Musk-owned SpaceX has a plan to draw carbon dioxide from the earth’s atmosphere and use it as rocket fuel.\nWhat Tesla Does:Founded in 2003 and based in Palo Alto, California, Tesla is a vertically integrated sustainable energy company that also aims to transition the world to electric mobility by making electric vehicles.\n\nBox\n\nThe Trade:Box, Inc. Director Daniel Levinsold a total of 128600 shares at an average price of $26.04. The insider received $3,348,245.17 from selling those shares.\nWhat’s Happening:Box recently reported better-than-expected Q3 EPS and sales results.\nWhat Box Does:Box was founded in 2005 as a natively built cloud file sync and sharing provider for enterprises. Box is headquartered in Redwood City, California.\n\nQUALCOMM\n\nThe Trade:QUALCOMM Incorporated Chief Technology Officer James H Thompson sold a total of 10000 shares at an average price of $183.39. The insider received $1,815,526.35 as a result of the transaction.\nWhat’s Happening:JPMorgan added Qualcomm to the firm's Analyst Focus List.\nWhat QUALCOMM Does:Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks.\n\nSouthwest Airlines\n\nThe Trade:Southwest Airlines Co. Director John T Montfordsold a total of 3230 shares at an average price of $43.88. The insider received $23,697.36 from selling those shares.\nWhat’s Happening:Goldman Sachs recently downgraded the stock from Neutral to Sell and lowered its price target from $59 to $36.\nWhat Southwest Airlines Does:Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded.","news_type":1},"isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607382419,"gmtCreate":1639490358973,"gmtModify":1639490374660,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607382419","repostId":"1128237305","repostType":4,"repost":{"id":"1128237305","pubTimestamp":1639489011,"share":"https://www.laohu8.com/m/news/1128237305?lang=&edition=full","pubTime":"2021-12-14 21:36","market":"us","language":"en","title":"Swiss to start Pfizer/BioNTech jab for children aged 5-11 in January","url":"https://stock-news.laohu8.com/highlight/detail?id=1128237305","media":"Reuters","summary":"Swiss health authorities will start administering the COVID-19 vaccination from Pfizer and BioNTech ","content":"<p>Swiss health authorities will start administering the COVID-19 vaccination from Pfizer and BioNTech to children aged five to eleven from next month and recommend kids get two doses of the shot.</p>\n<p>\"If they wish, parents or legal guardians can have their child vaccinated on the basis of an individual assessment of the benefits and risks, as soon as the vaccination is available,\" the Federal Office of Public Health said on Tuesday.</p>\n<p>Supplies should be available from the beginning of January, it added.</p>\n<p>The recommendation particularly applies to children who already have serious health risks owing to a chronic condition. The vaccination is recommended as a priority for children who have close contact with people at especially high risk in the same household who cannot obtain protection from vaccination, for example because they have a weakened immune system, it said.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Swiss to start Pfizer/BioNTech jab for children aged 5-11 in January</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSwiss to start Pfizer/BioNTech jab for children aged 5-11 in January\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/swiss-start-pfizer-biontech-jab-132632610.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Swiss health authorities will start administering the COVID-19 vaccination from Pfizer and BioNTech to children aged five to eleven from next month and recommend kids get two doses of the shot.\n\"If ...</p>\n\n<a href=\"https://finance.yahoo.com/news/swiss-start-pfizer-biontech-jab-132632610.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"https://finance.yahoo.com/news/swiss-start-pfizer-biontech-jab-132632610.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128237305","content_text":"Swiss health authorities will start administering the COVID-19 vaccination from Pfizer and BioNTech to children aged five to eleven from next month and recommend kids get two doses of the shot.\n\"If they wish, parents or legal guardians can have their child vaccinated on the basis of an individual assessment of the benefits and risks, as soon as the vaccination is available,\" the Federal Office of Public Health said on Tuesday.\nSupplies should be available from the beginning of January, it added.\nThe recommendation particularly applies to children who already have serious health risks owing to a chronic condition. The vaccination is recommended as a priority for children who have close contact with people at especially high risk in the same household who cannot obtain protection from vaccination, for example because they have a weakened immune system, it said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607382831,"gmtCreate":1639490318142,"gmtModify":1639490367815,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607382831","repostId":"2191930972","repostType":4,"repost":{"id":"2191930972","pubTimestamp":1639489168,"share":"https://www.laohu8.com/m/news/2191930972?lang=&edition=full","pubTime":"2021-12-14 21:39","market":"us","language":"en","title":"2 Warren Buffett Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2191930972","media":"Motley Fool","summary":"AbbVie and Royalty Pharma should be on every dividend investor's radar right now.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.</p>\n<p>As a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.</p>\n<p>Which Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks <b>AbbVie</b> (NYSE:ABBV) and <b>Royalty Pharma</b> (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.</p>\n<h2>AbbVie: A high-yield growth stock</h2>\n<p>Berkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest yields among major drug manufacturers.</p>\n<p>Second, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.</p>\n<p>Lastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.</p>\n<p>The net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.</p>\n<h2>Royalty Pharma: A dependable revenue stream</h2>\n<p>Royalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.</p>\n<p><img src=\"https://static.tigerbbs.com/a320f51af9bb7ac0d6359af7ed64161a\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>RPRX data by YCharts</p>\n<p>Why is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.</p>\n<p>Now, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Dividend Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Dividend Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4176":"多领域控股","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4559":"巴菲特持仓","BRK.A":"伯克希尔","BK4550":"红杉资本持仓","ABBV":"艾伯维公司","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4007":"制药","BRK.B":"伯克希尔B","RPRX":"Royalty Pharma plc"},"source_url":"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191930972","content_text":"Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.\nAs a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.\nWhich Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks AbbVie (NYSE:ABBV) and Royalty Pharma (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.\nAbbVie: A high-yield growth stock\nBerkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's one of the highest yields among major drug manufacturers.\nSecond, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.\nLastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.\nThe net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.\nRoyalty Pharma: A dependable revenue stream\nRoyalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.\n\nRPRX data by YCharts\nWhy is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.\nNow, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.","news_type":1},"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":690035279,"gmtCreate":1639612838631,"gmtModify":1639612838805,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690035279","repostId":"2191994940","repostType":4,"repost":{"id":"2191994940","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639608624,"share":"https://www.laohu8.com/m/news/2191994940?lang=&edition=full","pubTime":"2021-12-16 06:50","market":"us","language":"en","title":"Wall St ends higher; Fed to end bond purchases in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2191994940","media":"Reuters","summary":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow ","content":"<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends higher; Fed to end bond purchases in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends higher; Fed to end bond purchases in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-16 06:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Fed says it will end bond purchases in March</li>\n <li>Tech and healthcare the strongest sectors</li>\n <li>Indexes: Dow +1.08%, S&amp;P 500 +1.63%, Nasdaq +2.15%</li>\n</ul>\n<p>Dec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.</p>\n<p>Following its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.</p>\n<p>All three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an&nbsp;upbeat tone&nbsp;about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.</p>\n<p>\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"</p>\n<p>The S&amp;P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.</p>\n<p>For the session, the Dow Jones Industrial Average&nbsp;rose 1.08% to end at 35,927.43 points, while the S&amp;P 500&nbsp;gained 1.63% to 4,709.85.</p>\n<p>The Nasdaq Composite&nbsp;climbed 2.15% to 15,565.58.</p>\n<p>Volume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.</p>\n<p>Inflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.</p>\n<p>\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"</p>\n<p>Among the 11 S&amp;P 500 sector indexes, technology&nbsp;jumped 2.7% and healthcare&nbsp;rallied 2.1%.</p>\n<p>Apple Inc&nbsp;climbed 2.85% and Nvidia Corp&nbsp;rallied 7.49%, with both lifting the S&amp;P 500 more than any other stocks.</p>\n<p>The Philadelphia Semiconductor index&nbsp;jumped 3.7%.</p>\n<p>Albemarle Corp&nbsp;ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","AAPL":"苹果",".SPX":"S&P 500 Index","NVDA":"英伟达","ALB":"美国雅保",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191994940","content_text":"Fed says it will end bond purchases in March\nTech and healthcare the strongest sectors\nIndexes: Dow +1.08%, S&P 500 +1.63%, Nasdaq +2.15%\n\nDec 15 (Reuters) - Wall Street ended sharply higher on Wednesday after the Federal Reserve said it would end its pandemic-era bond purchases in March as it exits from policies enacted at the start of the health crisis.\nFollowing its two-day policy meeting, the Fed signaled its inflation target has been met, and its announcement on ending the bond purchases paved the way for three quarter-percentage-point interest rate increases by the end of 2022.\nAll three main U.S. stock indexes reversed earlier losses and climbed into positive territory. Wall Street extended those gains as Fed Chair Jerome Powell during his news conference struck an upbeat tone about the U.S. economic recovery and expressed willingness to raise interest rates as necessary to control inflation.\n\"What the markets are saying is, because the Fed is increasing their taper, maybe they feel inflation is under control,\" said Tom Martin, senior portfolio manager at Globalt Investments in Atlanta. \"They did what was expected. It’s going to add to the credibility for the Fed and that will be - on balance - neutral to positive for the markets.\"\nThe S&P 500's sharp rise on Wednesday erased almost all of its losses from earlier this week and left it just short of its record-high close on Friday.\nFor the session, the Dow Jones Industrial Average rose 1.08% to end at 35,927.43 points, while the S&P 500 gained 1.63% to 4,709.85.\nThe Nasdaq Composite climbed 2.15% to 15,565.58.\nVolume on U.S. exchanges was 12.2 billion shares, strong compared with the 11.6 billion average over the last 20 trading days.\nInflation and higher interest rates have become a major concern on Wall Street in recent months. Data on Tuesday showed producer prices increased more than expected in the 12 months through November, clocking their largest gain since 2010. Last week's consumer prices data showed the biggest gain in almost four decades.\n\"You had hedge funds positioned for the worst, in the terms of the worst for equities, coming in to the Fed statement,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles. \"Today, I think, is a function of sell the expectation and buy the news.\"\nAmong the 11 S&P 500 sector indexes, technology jumped 2.7% and healthcare rallied 2.1%.\nApple Inc climbed 2.85% and Nvidia Corp rallied 7.49%, with both lifting the S&P 500 more than any other stocks.\nThe Philadelphia Semiconductor index jumped 3.7%.\nAlbemarle Corp ended 1.67% lower after Goldman Sachs downgraded the lithium producer to \"sell\" from \"neutral.\"\nAdvancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 1.70-to-1 ratio favored advancers.\nThe S&P 500 posted 40 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 38 new highs and 545 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607382831,"gmtCreate":1639490318142,"gmtModify":1639490367815,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607382831","repostId":"2191930972","repostType":4,"repost":{"id":"2191930972","pubTimestamp":1639489168,"share":"https://www.laohu8.com/m/news/2191930972?lang=&edition=full","pubTime":"2021-12-14 21:39","market":"us","language":"en","title":"2 Warren Buffett Dividend Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2191930972","media":"Motley Fool","summary":"AbbVie and Royalty Pharma should be on every dividend investor's radar right now.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.</p>\n<p>As a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.</p>\n<p>Which Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks <b>AbbVie</b> (NYSE:ABBV) and <b>Royalty Pharma</b> (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.</p>\n<h2>AbbVie: A high-yield growth stock</h2>\n<p>Berkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the highest yields among major drug manufacturers.</p>\n<p>Second, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.</p>\n<p>Lastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.</p>\n<p>The net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.</p>\n<h2>Royalty Pharma: A dependable revenue stream</h2>\n<p>Royalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.</p>\n<p><img src=\"https://static.tigerbbs.com/a320f51af9bb7ac0d6359af7ed64161a\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>RPRX data by YCharts</p>\n<p>Why is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.</p>\n<p>Now, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Warren Buffett Dividend Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Warren Buffett Dividend Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 21:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4176":"多领域控股","BK4534":"瑞士信贷持仓","BK4139":"生物科技","BK4559":"巴菲特持仓","BRK.A":"伯克希尔","BK4550":"红杉资本持仓","ABBV":"艾伯维公司","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4007":"制药","BRK.B":"伯克希尔B","RPRX":"Royalty Pharma plc"},"source_url":"https://www.fool.com/investing/2021/12/14/2-warren-buffett-dividend-stocks-to-buy-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191930972","content_text":"Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.\nAs a result, most of Berkshire's top holdings over the past several decades have been well-established companies that offer top-notch shareholder rewards (share repurchases and dividends). Dividends have been particularly important to Berkshire's and Buffett's outstanding gains over the years, as dividends can be used to generate compounding returns when they are reinvested.\nWhich Warren Buffett dividend stock picks are the most appealing buys right now? The healthcare stocks AbbVie (NYSE:ABBV) and Royalty Pharma (NASDAQ:RPRX) are two intriguing Berkshire holdings that each pay a respectable dividend. Although these two healthcare stocks are a tad riskier than the average Berkshire investment, there is a solid bull case for both AbbVie and Royalty Pharma right now. Read on to find out more about these two Warren Buffett dividend stock picks.\nAbbVie: A high-yield growth stock\nBerkshire first bought AbbVie during the third quarter of 2020. Although Buffett's diversified holding company has since pared back its position in the Illinois-based drugmaker, AbbVie's shares are still a worthwhile buy for most income investors. AbbVie's stock is an appealing income play for three clear-cut reasons. First, the drugmaker pays out a handsome 4.5% dividend yield on an annualized basis. That's one of the highest yields among major drug manufacturers.\nSecond, AbbVie is a Dividend Aristocrat, meaning that it has a strong track record of raising its dividend on a regular basis. In fact, the company has boosted its yield by a whopping 225% since 2013.\nLastly, AbbVie has radically transformed its product portfolio ahead of the patent expiration for the flagship anti-inflammatory medicine Humira. The company now has two new high growth immunology assets with Skyrizi and Rinvoq, a strong and growing eye care franchise, several healthy avenues to explore for the commercial expansion of its Allergan aesthetics segment, an underappreciated migraine franchise, and two top-notch oncology drugs with Imbruvica and Venclexta.\nThe net result is that AbbVie's top line is forecast to rise by a respectable 6.6% in 2022, despite biosimilar competition for Humira.\nRoyalty Pharma: A dependable revenue stream\nRoyalty Pharma is a brand new addition to the Berkshire family of holdings. The diversified holding company jumped into this pharma stock in the third quarter of 2021 following a sharp pullback in its share price. The backstory is that Royalty went public in the middle of 2020 and initially became a big hit with investors. The company's shares, however, have since reversed course due to the raging political debate over prescription drug prices in the U.S., as well as the negative sentiment toward biopharma stocks in general this year.\n\nRPRX data by YCharts\nWhy is Royalty's stock a bargain at these levels? Although Royalty pays out a less-than-stellar 1.78% annualized dividend yield, the company sports a rock-solid business model. Royalty Pharma makes money by funding late-stage clinical assets in exchange for a share of future revenues. The reason this business model is attractive is because it largely eliminates the risk of investing in either early stage drugmakers or biopharmas with aging portfolios. Royalty, in effect, can cherry-pick the best new growth assets to fund, without having to deal with early to mid-stage clinical setbacks or steep drop-offs in revenue from patent expirations.\nNow, Royalty's dividend yield isn't going to make you rich, but it is a source of reliable income. And that high level of dependability is arguably worth the price of admission alone.","news_type":1},"isVote":1,"tweetType":1,"viewCount":292,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608287185,"gmtCreate":1638749466328,"gmtModify":1638749466328,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608287185","repostId":"1179313612","repostType":4,"repost":{"id":"1179313612","pubTimestamp":1638745398,"share":"https://www.laohu8.com/m/news/1179313612?lang=&edition=full","pubTime":"2021-12-06 07:03","market":"us","language":"en","title":"Game Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1179313612","media":"Barrons","summary":"Meme stock darling GameStop headlines this week’s earnings report lineup. The videogame retailer rep","content":"<p>Meme stock darling <a href=\"https://laohu8.com/S/GME\">GameStop</a> headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. <a href=\"https://laohu8.com/S/AZO\">AutoZone</a>, Casey’s <a href=\"https://laohu8.com/S/BGC\">General</a> Stores, and <a href=\"https://laohu8.com/S/TOL\">Toll Brothers</a> report earnings on Tuesday, followed by <a href=\"https://laohu8.com/S/BF.A\">Brown-Forman</a> and <a href=\"https://laohu8.com/S/CPB\">Campbell Soup</a> on Wednesday. <a href=\"https://laohu8.com/S/AVGO\">Broadcom</a>, <a href=\"https://laohu8.com/S/COST\">Costco</a> Wholesale, and <a href=\"https://laohu8.com/S/HRL\">Hormel</a> Foods round things out on Thursday.</p>\n<p>On Monday, <a href=\"https://laohu8.com/S/UNP\">Union Pacific</a> will hold a conference call to discuss its climate action plan. <a href=\"https://laohu8.com/S/MCK\">McKesson</a> and <a href=\"https://laohu8.com/S/LUV\">Southwest Airlines</a> host their 2021 investor days on Wednesday, followed by <a href=\"https://laohu8.com/S/CVS\">CVS Health</a> and <a href=\"https://laohu8.com/S/TSN\">Tyson</a> Foods on Thursday.</p>\n<p>The Federal Reserve’s report on consumer credit data for October will be released on Tuesday. On Thursday, the U.S. Labor Department reports initial jobless claims for the week ending on Dec. 4.</p>\n<p>The Bureau of Labor Statistics releases the consumer price index for November on Friday. The consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously.</p>\n<p><b>Monday 12/6</b></p>\n<p>Union Pacific holds a conference call to discuss its climate action plan.</p>\n<p><b>Tuesday 12/7</b></p>\n<p>AutoZone, Casey’s General Stores, and Toll Brothers announce quarterly results.</p>\n<p>The Federal Reserve reports on consumer credit data for October. After falling slightly last year, total outstanding consumer debt has risen an average of $20 billion a month through September, and stands at a record $4.37 trillion.</p>\n<p><b>Wednesday 12/8</b></p>\n<p>The BLS releases the Job Openings and Labor Turnover Survey. Economists forecast 10.5 million job openings on the last business day of October, only 600,000 less than the record high of 11.1 million in July.</p>\n<p><a href=\"https://laohu8.com/S/BF.B\">Brown-Forman</a>, Campbell Soup, and GameStop report earnings.</p>\n<p>McKesson and <a href=\"https://laohu8.com/S/OKSB\">Southwest</a> Airlines host their 2021 investor days.</p>\n<p><a href=\"https://laohu8.com/S/EW\">Edwards Lifesciences</a> holds an investor conference in Irvine, Calif. The company will discuss its product pipeline as well as its financial outlook for 2022.</p>\n<p>The Bank of Canada announces its monetary-policy decision. The central bank is expected to keep its key short-term interest rate unchanged at 0.25%. At its late-October meeting, the bank ended its quantitative-easing program and signaled that its first interest-rate hike would be earlier in 2022 than had been expected.</p>\n<p><b>Thursday 12/9</b></p>\n<p>Broadcom, Costco Wholesale, and Hormel Foods hold conference calls to discuss quarterly results.</p>\n<p>CVS Health and Tyson Foods host their annual investor days.</p>\n<p>The Department of Labor reports initial jobless claims for the week ending on Dec. 4. Jobless claims averaged 238,750 in November, the lowest since the beginning of the pandemic, and just 24,750 more than in February of 2020.</p>\n<p><b>Friday 12/10</b></p>\n<p>Archer-Daniels-Midland holds its global investor day.</p>\n<p><a href=\"https://laohu8.com/S/CNC\">Centene</a> holds an investor meeting and will provide financial guidance for 2022.</p>\n<p>The Bureau of Labor Statistics releases the consumer price index for November. Consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously. October’s 6.2% increase was the hottest the CPI has run in more than 30 years, and this past week Federal Reserve Chairman Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> finally ditched “transitory” when discussing inflation before the Senate Banking Committee.</p>\n<p>The University of Michigan releases its Consumer Sentiment index for December. Economists forecast a 66 reading, slightly less than the November data.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Game Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGame Stop, Toll Brothers, Costco, CVS, and Other Stocks to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-06 07:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/game-stop-toll-brothers-costco-cvs-and-other-stocks-to-watch-this-week-51638734413?mod=barrons-on-marketwatch><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stock darling GameStop headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. AutoZone, Casey’s General Stores, and Toll ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/game-stop-toll-brothers-costco-cvs-and-other-stocks-to-watch-this-week-51638734413?mod=barrons-on-marketwatch\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TOL":"托尔兄弟","CVS":"西维斯健康","BK4088":"住宅建筑","COST":"好市多","GME":"游戏驿站"},"source_url":"https://www.marketwatch.com/articles/game-stop-toll-brothers-costco-cvs-and-other-stocks-to-watch-this-week-51638734413?mod=barrons-on-marketwatch","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1179313612","content_text":"Meme stock darling GameStop headlines this week’s earnings report lineup. The videogame retailer reports results after the market closes on Wednesday. AutoZone, Casey’s General Stores, and Toll Brothers report earnings on Tuesday, followed by Brown-Forman and Campbell Soup on Wednesday. Broadcom, Costco Wholesale, and Hormel Foods round things out on Thursday.\nOn Monday, Union Pacific will hold a conference call to discuss its climate action plan. McKesson and Southwest Airlines host their 2021 investor days on Wednesday, followed by CVS Health and Tyson Foods on Thursday.\nThe Federal Reserve’s report on consumer credit data for October will be released on Tuesday. On Thursday, the U.S. Labor Department reports initial jobless claims for the week ending on Dec. 4.\nThe Bureau of Labor Statistics releases the consumer price index for November on Friday. The consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously.\nMonday 12/6\nUnion Pacific holds a conference call to discuss its climate action plan.\nTuesday 12/7\nAutoZone, Casey’s General Stores, and Toll Brothers announce quarterly results.\nThe Federal Reserve reports on consumer credit data for October. After falling slightly last year, total outstanding consumer debt has risen an average of $20 billion a month through September, and stands at a record $4.37 trillion.\nWednesday 12/8\nThe BLS releases the Job Openings and Labor Turnover Survey. Economists forecast 10.5 million job openings on the last business day of October, only 600,000 less than the record high of 11.1 million in July.\nBrown-Forman, Campbell Soup, and GameStop report earnings.\nMcKesson and Southwest Airlines host their 2021 investor days.\nEdwards Lifesciences holds an investor conference in Irvine, Calif. The company will discuss its product pipeline as well as its financial outlook for 2022.\nThe Bank of Canada announces its monetary-policy decision. The central bank is expected to keep its key short-term interest rate unchanged at 0.25%. At its late-October meeting, the bank ended its quantitative-easing program and signaled that its first interest-rate hike would be earlier in 2022 than had been expected.\nThursday 12/9\nBroadcom, Costco Wholesale, and Hormel Foods hold conference calls to discuss quarterly results.\nCVS Health and Tyson Foods host their annual investor days.\nThe Department of Labor reports initial jobless claims for the week ending on Dec. 4. Jobless claims averaged 238,750 in November, the lowest since the beginning of the pandemic, and just 24,750 more than in February of 2020.\nFriday 12/10\nArcher-Daniels-Midland holds its global investor day.\nCentene holds an investor meeting and will provide financial guidance for 2022.\nThe Bureau of Labor Statistics releases the consumer price index for November. Consensus estimate is for a 6.7% year-over-year jump, half a percentage point more than in October. The core CPI, which excludes volatile food and energy prices, is expected to rise 4.8% versus 4.6% previously. October’s 6.2% increase was the hottest the CPI has run in more than 30 years, and this past week Federal Reserve Chairman Jerome Powell finally ditched “transitory” when discussing inflation before the Senate Banking Committee.\nThe University of Michigan releases its Consumer Sentiment index for December. Economists forecast a 66 reading, slightly less than the November data.","news_type":1},"isVote":1,"tweetType":1,"viewCount":39,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693805026,"gmtCreate":1639994340064,"gmtModify":1639994618768,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693805026","repostId":"1100813350","repostType":4,"repost":{"id":"1100813350","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639993227,"share":"https://www.laohu8.com/m/news/1100813350?lang=&edition=full","pubTime":"2021-12-20 17:40","market":"us","language":"en","title":"Novavax shares rose more than 8% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1100813350","media":"Tiger Newspress","summary":"Novavax shares rose more than 8% in premarket trading.The stock rose 11.49% on last Friday as the WH","content":"<p>Novavax&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/41122ce5efa068fd13d80b295b66e434\" tg-width=\"711\" tg-height=\"598\" width=\"100%\" height=\"auto\">The&nbsp;stock&nbsp;rose&nbsp;11.49%&nbsp;on&nbsp;last&nbsp;Friday&nbsp;as&nbsp;the WHO&nbsp;granted emergency authorization to a Covid-19 vaccine produced by Maryland-based Novavax and the Serum Institute of India.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares rose more than 8% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares rose more than 8% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-20 17:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;rose&nbsp;more&nbsp;than&nbsp;8%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/41122ce5efa068fd13d80b295b66e434\" tg-width=\"711\" tg-height=\"598\" width=\"100%\" height=\"auto\">The&nbsp;stock&nbsp;rose&nbsp;11.49%&nbsp;on&nbsp;last&nbsp;Friday&nbsp;as&nbsp;the WHO&nbsp;granted emergency authorization to a Covid-19 vaccine produced by Maryland-based Novavax and the Serum Institute of India.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100813350","content_text":"Novavax shares rose more than 8% in premarket trading.The stock rose 11.49% on last Friday as the WHO granted emergency authorization to a Covid-19 vaccine produced by Maryland-based Novavax and the Serum Institute of India.","news_type":1},"isVote":1,"tweetType":1,"viewCount":931,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608962717,"gmtCreate":1638598700145,"gmtModify":1638598700232,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Pls like n comment....&nbsp;","listText":"Pls like n comment....&nbsp;","text":"Pls like n comment....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608962717","repostId":"1158981658","repostType":4,"repost":{"id":"1158981658","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638545456,"share":"https://www.laohu8.com/m/news/1158981658?lang=&edition=full","pubTime":"2021-12-03 23:30","market":"us","language":"en","title":"Tesla's Musk over halfway through his pledge with nearly $11 bln stake sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1158981658","media":"Reuters","summary":"Dec 3  - Tesla Inc Chief Executive Elon Musk has sold nearly $11 billion worth of shares since the world's richest person polled Twitter users about offloading 10% of his stake in the electric-car maker.He has sold a combined 10.1 million shares, which is over half of the stake that he had pledged to sell, and has acquired 10.7 million shares by exercising options, since Nov. 8.Musk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed. He owned a combination of about 244 million","content":"<p>Dec 3 (Reuters) - Tesla Inc&nbsp;Chief Executive Elon Musk has sold nearly $11 billion worth of shares since the world's richest person polled Twitter users about offloading 10% of his stake in the electric-car maker.</p>\n<p>He has sold a combined 10.1 million shares, which is over half of the stake that he had pledged to sell, and has acquired 10.7 million shares by exercising options, since Nov. 8.</p>\n<p>Here is a string of transactions he has done:</p>\n<table>\n <tbody>\n  <tr>\n   <td>DATE</td>\n   <td>SHARES ACQUIRED</td>\n   <td>SHARES SOLD</td>\n   <td>GROSS PROCEEDS</td>\n  </tr>\n  <tr>\n   <td>NOV. 8</td>\n   <td>2.2 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 8</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$1.10 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 9</td>\n   <td></td>\n   <td>3.1 mln</td>\n   <td>$3.35 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 10</td>\n   <td></td>\n   <td>500,000</td>\n   <td>$527.3 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 11</td>\n   <td></td>\n   <td>639,737</td>\n   <td>$687.3 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 12</td>\n   <td></td>\n   <td>1.2 mln</td>\n   <td>$1.24 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 15</td>\n   <td>2.1 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 15</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$930.7 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 16</td>\n   <td>2.1 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 16</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$973.4 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 23</td>\n   <td>2.15 mln</td>\n   <td>934,091</td>\n   <td>$1.05 bln</td>\n  </tr>\n  <tr>\n   <td>DEC. 2</td>\n   <td>2.1 mln</td>\n   <td>934,091</td>\n   <td>$1.01 bln</td>\n  </tr>\n  <tr>\n   <td>Total</td>\n   <td>10.7 mln</td>\n   <td>10.1 mln</td>\n   <td>$10.87 bln</td>\n  </tr>\n </tbody>\n</table>\n<p><b>HOW DID MUSK SELL?</b></p>\n<p>Musk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed. He owned a combination of about 244 million shares through his trust and stock options, bringing his stake in Tesla to about 23% as of June 30. It included 170 million shares held by his trust.</p>\n<p>The tweet was vague. Musk did not outline if he was intending to offload 10% of his shares he indirectly owned through the trust or if his stock options were also part of the deal.</p>\n<p>Following a flurry of options exercise, Musk still has an option to buy about 10 million more shares at $6.24 each, which expires in August next year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla's Musk over halfway through his pledge with nearly $11 bln stake sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla's Musk over halfway through his pledge with nearly $11 bln stake sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-03 23:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 3 (Reuters) - Tesla Inc&nbsp;Chief Executive Elon Musk has sold nearly $11 billion worth of shares since the world's richest person polled Twitter users about offloading 10% of his stake in the electric-car maker.</p>\n<p>He has sold a combined 10.1 million shares, which is over half of the stake that he had pledged to sell, and has acquired 10.7 million shares by exercising options, since Nov. 8.</p>\n<p>Here is a string of transactions he has done:</p>\n<table>\n <tbody>\n  <tr>\n   <td>DATE</td>\n   <td>SHARES ACQUIRED</td>\n   <td>SHARES SOLD</td>\n   <td>GROSS PROCEEDS</td>\n  </tr>\n  <tr>\n   <td>NOV. 8</td>\n   <td>2.2 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 8</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$1.10 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 9</td>\n   <td></td>\n   <td>3.1 mln</td>\n   <td>$3.35 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 10</td>\n   <td></td>\n   <td>500,000</td>\n   <td>$527.3 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 11</td>\n   <td></td>\n   <td>639,737</td>\n   <td>$687.3 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 12</td>\n   <td></td>\n   <td>1.2 mln</td>\n   <td>$1.24 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 15</td>\n   <td>2.1 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 15</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$930.7 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 16</td>\n   <td>2.1 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 16</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$973.4 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 23</td>\n   <td>2.15 mln</td>\n   <td>934,091</td>\n   <td>$1.05 bln</td>\n  </tr>\n  <tr>\n   <td>DEC. 2</td>\n   <td>2.1 mln</td>\n   <td>934,091</td>\n   <td>$1.01 bln</td>\n  </tr>\n  <tr>\n   <td>Total</td>\n   <td>10.7 mln</td>\n   <td>10.1 mln</td>\n   <td>$10.87 bln</td>\n  </tr>\n </tbody>\n</table>\n<p><b>HOW DID MUSK SELL?</b></p>\n<p>Musk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed. He owned a combination of about 244 million shares through his trust and stock options, bringing his stake in Tesla to about 23% as of June 30. It included 170 million shares held by his trust.</p>\n<p>The tweet was vague. Musk did not outline if he was intending to offload 10% of his shares he indirectly owned through the trust or if his stock options were also part of the deal.</p>\n<p>Following a flurry of options exercise, Musk still has an option to buy about 10 million more shares at $6.24 each, which expires in August next year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158981658","content_text":"Dec 3 (Reuters) - Tesla Inc Chief Executive Elon Musk has sold nearly $11 billion worth of shares since the world's richest person polled Twitter users about offloading 10% of his stake in the electric-car maker.\nHe has sold a combined 10.1 million shares, which is over half of the stake that he had pledged to sell, and has acquired 10.7 million shares by exercising options, since Nov. 8.\nHere is a string of transactions he has done:\n\n\n\nDATE\nSHARES ACQUIRED\nSHARES SOLD\nGROSS PROCEEDS\n\n\nNOV. 8\n2.2 mln\n\n\n\n\nNOV. 8\n\n934,091\n$1.10 bln\n\n\nNOV. 9\n\n3.1 mln\n$3.35 bln\n\n\nNOV. 10\n\n500,000\n$527.3 mln\n\n\nNOV. 11\n\n639,737\n$687.3 mln\n\n\nNOV. 12\n\n1.2 mln\n$1.24 bln\n\n\nNOV. 15\n2.1 mln\n\n\n\n\nNOV. 15\n\n934,091\n$930.7 mln\n\n\nNOV. 16\n2.1 mln\n\n\n\n\nNOV. 16\n\n934,091\n$973.4 mln\n\n\nNOV. 23\n2.15 mln\n934,091\n$1.05 bln\n\n\nDEC. 2\n2.1 mln\n934,091\n$1.01 bln\n\n\nTotal\n10.7 mln\n10.1 mln\n$10.87 bln\n\n\n\nHOW DID MUSK SELL?\nMusk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed. He owned a combination of about 244 million shares through his trust and stock options, bringing his stake in Tesla to about 23% as of June 30. It included 170 million shares held by his trust.\nThe tweet was vague. Musk did not outline if he was intending to offload 10% of his shares he indirectly owned through the trust or if his stock options were also part of the deal.\nFollowing a flurry of options exercise, Musk still has an option to buy about 10 million more shares at $6.24 each, which expires in August next year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":46,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601317906,"gmtCreate":1638491417030,"gmtModify":1638491417030,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/601317906","repostId":"2188484275","repostType":4,"repost":{"id":"2188484275","pubTimestamp":1638490382,"share":"https://www.laohu8.com/m/news/2188484275?lang=&edition=full","pubTime":"2021-12-03 08:13","market":"us","language":"en","title":"Singapore had a new billionaire for a few hours before Grab shares slid in US debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2188484275","media":"The Straits Times","summary":"SINGAPORE (BLOOMBERG) - \"The stock will go up and it will go down,\" said Anthony Tan, co-founder of ","content":"<div>\n<p>SINGAPORE (BLOOMBERG) - \"The stock will go up and it will go down,\" said Anthony Tan, co-founder of Grab Holdings, moments after Nasdaq's bell-ringing ceremony in Singapore on Thursday night (Dec 2), ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/singapore-had-a-new-billionaire-for-a-few-hours-before-grab-shares-slid\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore had a new billionaire for a few hours before Grab shares slid in US debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore had a new billionaire for a few hours before Grab shares slid in US debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 08:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/companies-markets/singapore-had-a-new-billionaire-for-a-few-hours-before-grab-shares-slid><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE (BLOOMBERG) - \"The stock will go up and it will go down,\" said Anthony Tan, co-founder of Grab Holdings, moments after Nasdaq's bell-ringing ceremony in Singapore on Thursday night (Dec 2), ...</p>\n\n<a href=\"http://www.straitstimes.com/business/companies-markets/singapore-had-a-new-billionaire-for-a-few-hours-before-grab-shares-slid\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"source_url":"http://www.straitstimes.com/business/companies-markets/singapore-had-a-new-billionaire-for-a-few-hours-before-grab-shares-slid","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188484275","content_text":"SINGAPORE (BLOOMBERG) - \"The stock will go up and it will go down,\" said Anthony Tan, co-founder of Grab Holdings, moments after Nasdaq's bell-ringing ceremony in Singapore on Thursday night (Dec 2), the first such event held in Southeast Asia.\nHe was right on the money. Grab soared in pre-market trading in New York but after opening 18 per cent higher at US$13.06 the shares tumbled 20.5 per cent to close at US$8.75 on its first day.\nThe stock made its debut after the ride-hailing and delivery company completed its merger with the blank-cheque firm of Brad Gerstner's Altimeter Capital Management, the largest deal yet to close for a special purpose acquisition company (Spac).\nThe slide wiped about US$17 billion (S$23.3 billion) from the market value of the company and meant that Mr Tan's stake, initially worth more than a billion dollars, ended at US$725 million, according to the Bloomberg Billionaires Index.\nGrab has yet to post a profit, but investors had largely welcomed the transaction, which raised US$4.5 billion in gross proceeds. Those include US$4 billion in private investment in public equity, or PIPE, marking the biggest US public market debut by a South-east Asian company. Temasek Holdings, BlackRock and Fidelity International are among those that joined the PIPE.\nThe timing for going public though wasn't optimal. The Covid-19 pandemic has severely hampered ride-hailing businesses, and the Omicron variant is causing new limits on travel. Grab's home country of Singapore banned entry from seven African nations last week, and the government said on Thursday it had detected two imported cases of Omicron.\nIt had already been a turbulent year for Grab. Its merger with Altimeter Growth Corp, announced in April, got delayed due to an audit of the past three years' accounts, sending Altimeter shares for a wild ride. At the same time, the Spac boom that's attracted billions of dollars in the past couple of years has shown signs of easing amid increased regulatory scrutiny.\nMr Tan, whose great-grandfather was a taxi driver, was inspired to start Grab while working on his MBA at Harvard Business School more than a decade ago. He gave up his family's business, one of the biggest auto distributors in Malaysia, and instead started a taxi-hailing service then known as MyTeksi with his Harvard classmate Tan Hooi Ling. The project was later relocated to Singapore after raising money for a regional expansion and was rebranded as Grab in 2016. The company now also does food delivery, online payments and financial services.\nBecause of Grab's share-class structure, Mr Anthony Tan has 60.4 per cent voting rights even though he owns just 2.2 per cent of the company. If he fully exercises his stock options, his voting rights will increase to 66.11 per cent, according to a recent filing.\nEven with today's slide, the deal has created considerable wealth for other key executives of the Singapore company. The holdings of co-founder Tan Hooi Ling and president Ming Maa are now worth US$224 million and US$126 million, respectively.\nBut it's SoftBank Group, which poured about US$3 billion into Grab through a series of investments starting in 2014, that has made the most from the listing. Its 18.6 per cent holding is currently worth US$6.1 billion. Uber Technologies and Didi Chuxing Technology have stakes worth US$4.7 billion and US$2.5 billion, respectively.\nWhile Grab has generated wealth, its loss widened to US$988 million in the third quarter from US$621 million in the same period last year as revenue declined about 9 per cent to US$157 million. The increase in losses was mainly driven by non-cash expenses, and a \"significant portion\" of such costs should drop after the business combination.\nThe ongoing pandemic also took a toll on Grab's operations as demand for mobility services dwindled amid stricter lockdowns in Vietnam and restrictions across the region. Moreover, the company is facing growing competition after its Indonesian rival, Gojek, merged with e-commerce provider PT Tokopedia. GoTo, the combined entity, is preparing for an initial public offering at home and in the United States next year.\nBut Mr Anthony Tan remains confident that things will get better for Grab as more people get vaccinated in the region and opt to pursue the strategy of living with Covid-19.\n\"We are confident about our business,\" he said in an interview on Thursday. \"The business is tracking well,\" in terms of meeting this year's target of gross merchandise value of US$15 billion to US$15.5 billion, he added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691541703,"gmtCreate":1640224124906,"gmtModify":1640224153015,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691541703","repostId":"2193113147","repostType":4,"repost":{"id":"2193113147","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640213688,"share":"https://www.laohu8.com/m/news/2193113147?lang=&edition=full","pubTime":"2021-12-23 06:54","market":"us","language":"en","title":"Wall St mints strong gains on rosy economic data, encouraging Omicron update","url":"https://stock-news.laohu8.com/highlight/detail?id=2193113147","media":"Reuters","summary":"* Tesla jumps as CEO Musk says he has sold 'enough' stock. * Pfizer rises as oral COVID-19 pill wins approval. Dec 22  - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.The S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of","content":"<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St mints strong gains on rosy economic data, encouraging Omicron update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St mints strong gains on rosy economic data, encouraging Omicron update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-23 06:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Consumer confidence index increases in December</p>\n<p>* U.S. Q3 economic growth revised slightly higher</p>\n<p>* Tesla jumps as CEO Musk says he has sold 'enough' stock</p>\n<p>* Pfizer rises as oral COVID-19 pill wins approval</p>\n<p>* Indexes up: Dow 0.74%, S&amp;P 1.02%, Nasdaq 1.18% </p>\n<p>Dec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.</p>\n<p>The S&amp;P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.</p>\n<p>A South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.</p>\n<p>“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.</p>\n<p>The Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&amp;P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.</p>\n<p>All major S&amp;P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.</p>\n<p>Tesla Inc shares rose 7.5%, boosting the S&amp;P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.</p>\n<p>U.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.</p>\n<p>Other reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.</p>\n<p>In another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.</p>\n<p>The benchmark S&amp;P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.</p>\n<p>The market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.</p>\n<p>About 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BK4568":"美国抗疫概念",".DJI":"道琼斯","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药",".IXIC":"NASDAQ Composite","COMP":"Compass, Inc.","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193113147","content_text":"* Consumer confidence index increases in December\n* U.S. Q3 economic growth revised slightly higher\n* Tesla jumps as CEO Musk says he has sold 'enough' stock\n* Pfizer rises as oral COVID-19 pill wins approval\n* Indexes up: Dow 0.74%, S&P 1.02%, Nasdaq 1.18% \nDec 22 (Reuters) - Wall Street's main indexes powered higher on Wednesday in a broad rally after upbeat economic data and hopeful developments about the severity of the Omicron coronavirus variant that is sweeping the world.\nThe S&P 500 gained at least 1% for a second straight session, putting it near record levels, as volatility has ratcheted up in the last month of 2021 following the arrival of Omicron and an otherwise strong year for equities.\nA South African study suggested reduced risks of hospitalization and severe disease in people infected with the Omicron variant versus the Delta one, but World Health Organization officials cautioned that it was too soon to draw firm conclusions.\n“We are still struggling for direction in the face of the Omicron outbreak, but in the past few days ... more and more evidence is building that the strain is potentially less severe than prior strains, specifically Delta, which bodes well for economic momentum in 2022,” said Mike Stritch, chief investment officer at BMO Wealth Management.\nThe Dow Jones Industrial Average rose 261.19 points, or 0.74%, to 35,753.89, the S&P 500 gained 47.33 points, or 1.02%, to 4,696.56 and the Nasdaq Composite added 180.81 points, or 1.18%, to 15,521.89.\nAll major S&P 500 sectors gained, with the consumer discretionary group up 1.7% and technology up 1.3%.\nTesla Inc shares rose 7.5%, boosting the S&P 500 and Nasdaq. Tesla Chief Executive Elon Musk said in an interview he has sold \"enough stock\" following several weeks of share sales by the billionaire.\nU.S. consumer confidence improved further in December, suggesting the economy would continue to expand in 2022. The survey from the Conference Board showed more consumers planned to buy a house and big-ticket items such as motor vehicles and major household appliances as well as go on vacation over the next six months.\nOther reports showed U.S. home sales increased for a third straight month in November, and that gross domestic product increased at a 2.3% annualized rate in the July-September quarter, revised up from the 2.1% rate estimated last month.\nIn another encouraging development against the pandemic, the United States authorized Pfizer Inc's oral antiviral COVID-19 pill for at-risk people aged 12 and above, making it the first at-home treatment for the coronavirus. Pfizer shares rose 1%.\nThe benchmark S&P 500 is now up 25% so far in 2021. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022 to rein in inflation.\nThe market is \"certainly at an extended level of valuation,\" said Rick Meckler, partner at Cherry Lane Investments in New Vernon, New Jersey. “Next year is a more difficult picture, but if inflation is going to be part of the problem, I think investors will certainly choose stocks over bonds.”\nAdvancing issues outnumbered declining ones on the NYSE by a 3.17-to-1 ratio; on Nasdaq, a 1.65-to-1 ratio favored advancers.\nThe S&P 500 posted 15 new 52-week highs and no new lows; the Nasdaq Composite recorded 35 new highs and 99 new lows.\nAbout 8.6 billion shares changed hands in U.S. exchanges, below the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":812,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693805356,"gmtCreate":1639994360595,"gmtModify":1639994618924,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693805356","repostId":"1150927570","repostType":4,"isVote":1,"tweetType":1,"viewCount":943,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605049473,"gmtCreate":1639096241192,"gmtModify":1639096241313,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Please like and comment","listText":"Please like and comment","text":"Please like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605049473","repostId":"2190964556","repostType":4,"repost":{"id":"2190964556","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639090919,"share":"https://www.laohu8.com/m/news/2190964556?lang=&edition=full","pubTime":"2021-12-10 07:01","market":"us","language":"en","title":"Wall St closes lower ahead of inflation data, Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2190964556","media":"Reuters","summary":"Wall Street closed lower on Thursday as investors banked some profits after three straight days of g","content":"<p>Wall Street closed lower on Thursday as investors banked some profits after three straight days of gains and turned their focus toward upcoming inflation data and how it might influence the Federal Reserve's meeting next week.</p>\n<p>The Nasdaq was down more sharply than the S&amp;P 500 while the Dow was virtually flat, ending down less than 1 point.</p>\n<p>Investors were in a waiting game ahead of U.S. consumer prices index inflation data due Friday morning. A higher-than-expected reading would strengthen the case for a policy tightening decision at the U.S. central bank's meeting.</p>\n<p>In the first three days of the week, the Nasdaq rallied 4.7%, the S&amp;P advanced 3.6% and the Dow gained 3.4% as fears abated about the latest coronavirus variant Omicron.</p>\n<p>\"We had a rip roaring rally. There's still nervous people out there,\" said Dennis Dick, head of markets structure, proprietary trader at Bright Trading LLC in Las Vegas.</p>\n<p>\"We'd a Omicron relief rally but the underlying problem still remains, that the Fed's taking the punchbowl away.\"</p>\n<p>Joe Quinlan, chief market strategist for the CIO office of Bank of America, said investors may be taking profits and pausing buying after the three days of gains.</p>\n<p>\"Also there may be a little risk-off trade ahead of the CPI number on Friday,\" he said. \"If it comes in hotter than expected it really shines the light and the focus on the Fed meeting. The pressure would build on the Fed for a faster tapering.\"</p>\n<p>Fed Chair Powell signaled last week that the meeting would include a discussion about a faster tapering of bond-buying.</p>\n<p>\"It would reaffirm in many people's minds that the Fed is behind the curve,\" said Quinlan.</p>\n<p>If the inflation number implies a need to hike rates faster, this \"would put pressure on technology and give a bid to cyclicals\" he said.</p>\n<p>\"You'd want to buy the companies that could pass on these higher costs to consumers. That undermines the growth story. You want to own more cyclicals and value than growth,\" said Quinlan.</p>\n<p>A Reuters poll of economists predicted the Fed would raise rates by 25 basis points to 0.25-0.50% in the third quarter of next year. However, most saw the risk that a hike comes even sooner.</p>\n<p>The Dow Jones Industrial Average fell 0.06 points to 35,754.69, the S&amp;P 500 lost 33.76 points, or 0.72%, to 4,667.45 and the Nasdaq Composite dropped 269.62 points, or 1.71%, to 15,517.37.</p>\n<p>Nine of the 11 major S&amp;P sectors declined, with consumer discretionary down 1.7%, losing the most and real estate , down 1.4%, and information technology&nbsp;falling 1%, showing the next biggest losses.</p>\n<p>The only sector gainers were healthcare up 0.2% and consumer staples which clung to a 0.06% advance.</p>\n<p>Healthcare was boosted by a CVS Health Corp share gain of 4.5% after the drugstore operator raised its 2021 profit forecast.</p>\n<p>In consumer staples, heavyweight electric car maker Tesla&nbsp;was the biggest percentage decliner, falling 6%.</p>\n<p>Markets have seesawed since late November when the Omicron variant was discovered. Investors worried it could upend a global recovery at a time of surging inflation with Fed commentary exacerbating volatility.</p>\n<p>Wall Street's main indexes were supported this week by an update showing Pfizer and BioNTech's vaccine offered some protection against the Omicron variant.</p>\n<p>Data showed initial claims for state unemployment benefits tumbled 43,000 last week to 184,000, the lowest level in more than 52 years.</p>\n<p>GameStop Corp fell 10% after the video game retailer popular among retail investors said it was issued a subpoena by the U.S. securities regulator back in August for documents on an investigation into its share trading activity.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 3.03-to-1 ratio; on Nasdaq, a 3.05-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 23 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 34 new highs and 68 new lows.</p>\n<p>On U.S. exchanges 9.75 billion shares changed hands compared with the 11.41 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St closes lower ahead of inflation data, Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St closes lower ahead of inflation data, Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-10 07:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street closed lower on Thursday as investors banked some profits after three straight days of gains and turned their focus toward upcoming inflation data and how it might influence the Federal Reserve's meeting next week.</p>\n<p>The Nasdaq was down more sharply than the S&amp;P 500 while the Dow was virtually flat, ending down less than 1 point.</p>\n<p>Investors were in a waiting game ahead of U.S. consumer prices index inflation data due Friday morning. A higher-than-expected reading would strengthen the case for a policy tightening decision at the U.S. central bank's meeting.</p>\n<p>In the first three days of the week, the Nasdaq rallied 4.7%, the S&amp;P advanced 3.6% and the Dow gained 3.4% as fears abated about the latest coronavirus variant Omicron.</p>\n<p>\"We had a rip roaring rally. There's still nervous people out there,\" said Dennis Dick, head of markets structure, proprietary trader at Bright Trading LLC in Las Vegas.</p>\n<p>\"We'd a Omicron relief rally but the underlying problem still remains, that the Fed's taking the punchbowl away.\"</p>\n<p>Joe Quinlan, chief market strategist for the CIO office of Bank of America, said investors may be taking profits and pausing buying after the three days of gains.</p>\n<p>\"Also there may be a little risk-off trade ahead of the CPI number on Friday,\" he said. \"If it comes in hotter than expected it really shines the light and the focus on the Fed meeting. The pressure would build on the Fed for a faster tapering.\"</p>\n<p>Fed Chair Powell signaled last week that the meeting would include a discussion about a faster tapering of bond-buying.</p>\n<p>\"It would reaffirm in many people's minds that the Fed is behind the curve,\" said Quinlan.</p>\n<p>If the inflation number implies a need to hike rates faster, this \"would put pressure on technology and give a bid to cyclicals\" he said.</p>\n<p>\"You'd want to buy the companies that could pass on these higher costs to consumers. That undermines the growth story. You want to own more cyclicals and value than growth,\" said Quinlan.</p>\n<p>A Reuters poll of economists predicted the Fed would raise rates by 25 basis points to 0.25-0.50% in the third quarter of next year. However, most saw the risk that a hike comes even sooner.</p>\n<p>The Dow Jones Industrial Average fell 0.06 points to 35,754.69, the S&amp;P 500 lost 33.76 points, or 0.72%, to 4,667.45 and the Nasdaq Composite dropped 269.62 points, or 1.71%, to 15,517.37.</p>\n<p>Nine of the 11 major S&amp;P sectors declined, with consumer discretionary down 1.7%, losing the most and real estate , down 1.4%, and information technology&nbsp;falling 1%, showing the next biggest losses.</p>\n<p>The only sector gainers were healthcare up 0.2% and consumer staples which clung to a 0.06% advance.</p>\n<p>Healthcare was boosted by a CVS Health Corp share gain of 4.5% after the drugstore operator raised its 2021 profit forecast.</p>\n<p>In consumer staples, heavyweight electric car maker Tesla&nbsp;was the biggest percentage decliner, falling 6%.</p>\n<p>Markets have seesawed since late November when the Omicron variant was discovered. Investors worried it could upend a global recovery at a time of surging inflation with Fed commentary exacerbating volatility.</p>\n<p>Wall Street's main indexes were supported this week by an update showing Pfizer and BioNTech's vaccine offered some protection against the Omicron variant.</p>\n<p>Data showed initial claims for state unemployment benefits tumbled 43,000 last week to 184,000, the lowest level in more than 52 years.</p>\n<p>GameStop Corp fell 10% after the video game retailer popular among retail investors said it was issued a subpoena by the U.S. securities regulator back in August for documents on an investigation into its share trading activity.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 3.03-to-1 ratio; on Nasdaq, a 3.05-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 23 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 34 new highs and 68 new lows.</p>\n<p>On U.S. exchanges 9.75 billion shares changed hands compared with the 11.41 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","SQQQ":"纳指三倍做空ETF","BK4555":"新能源车","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4196":"保健护理服务","DOG":"道指反向ETF","GME":"游戏驿站","QLD":"纳指两倍做多ETF",".DJI":"道琼斯","BK4527":"明星科技股","BK4550":"红杉资本持仓",".IXIC":"NASDAQ Composite","TQQQ":"纳指三倍做多ETF","SDOW":"道指三倍做空ETF-ProShares",".SPX":"S&P 500 Index","BK4076":"电脑与电子产品零售","PSQ":"纳指反向ETF","BK4551":"寇图资本持仓","BK4547":"WSB热门概念","CVS":"西维斯健康","UDOW":"道指三倍做多ETF-ProShares","QQQ":"纳指100ETF","BK4504":"桥水持仓","BK4099":"汽车制造商","BK4548":"巴美列捷福持仓","TSLA":"特斯拉","DJX":"1/100道琼斯","PFE":"辉瑞","DXD":"道指两倍做空ETF","QID":"纳指两倍做空ETF","DDM":"道指两倍做多ETF","CPI":"IQ Real Return ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190964556","content_text":"Wall Street closed lower on Thursday as investors banked some profits after three straight days of gains and turned their focus toward upcoming inflation data and how it might influence the Federal Reserve's meeting next week.\nThe Nasdaq was down more sharply than the S&P 500 while the Dow was virtually flat, ending down less than 1 point.\nInvestors were in a waiting game ahead of U.S. consumer prices index inflation data due Friday morning. A higher-than-expected reading would strengthen the case for a policy tightening decision at the U.S. central bank's meeting.\nIn the first three days of the week, the Nasdaq rallied 4.7%, the S&P advanced 3.6% and the Dow gained 3.4% as fears abated about the latest coronavirus variant Omicron.\n\"We had a rip roaring rally. There's still nervous people out there,\" said Dennis Dick, head of markets structure, proprietary trader at Bright Trading LLC in Las Vegas.\n\"We'd a Omicron relief rally but the underlying problem still remains, that the Fed's taking the punchbowl away.\"\nJoe Quinlan, chief market strategist for the CIO office of Bank of America, said investors may be taking profits and pausing buying after the three days of gains.\n\"Also there may be a little risk-off trade ahead of the CPI number on Friday,\" he said. \"If it comes in hotter than expected it really shines the light and the focus on the Fed meeting. The pressure would build on the Fed for a faster tapering.\"\nFed Chair Powell signaled last week that the meeting would include a discussion about a faster tapering of bond-buying.\n\"It would reaffirm in many people's minds that the Fed is behind the curve,\" said Quinlan.\nIf the inflation number implies a need to hike rates faster, this \"would put pressure on technology and give a bid to cyclicals\" he said.\n\"You'd want to buy the companies that could pass on these higher costs to consumers. That undermines the growth story. You want to own more cyclicals and value than growth,\" said Quinlan.\nA Reuters poll of economists predicted the Fed would raise rates by 25 basis points to 0.25-0.50% in the third quarter of next year. However, most saw the risk that a hike comes even sooner.\nThe Dow Jones Industrial Average fell 0.06 points to 35,754.69, the S&P 500 lost 33.76 points, or 0.72%, to 4,667.45 and the Nasdaq Composite dropped 269.62 points, or 1.71%, to 15,517.37.\nNine of the 11 major S&P sectors declined, with consumer discretionary down 1.7%, losing the most and real estate , down 1.4%, and information technology falling 1%, showing the next biggest losses.\nThe only sector gainers were healthcare up 0.2% and consumer staples which clung to a 0.06% advance.\nHealthcare was boosted by a CVS Health Corp share gain of 4.5% after the drugstore operator raised its 2021 profit forecast.\nIn consumer staples, heavyweight electric car maker Tesla was the biggest percentage decliner, falling 6%.\nMarkets have seesawed since late November when the Omicron variant was discovered. Investors worried it could upend a global recovery at a time of surging inflation with Fed commentary exacerbating volatility.\nWall Street's main indexes were supported this week by an update showing Pfizer and BioNTech's vaccine offered some protection against the Omicron variant.\nData showed initial claims for state unemployment benefits tumbled 43,000 last week to 184,000, the lowest level in more than 52 years.\nGameStop Corp fell 10% after the video game retailer popular among retail investors said it was issued a subpoena by the U.S. securities regulator back in August for documents on an investigation into its share trading activity.\nDeclining issues outnumbered advancing ones on the NYSE by a 3.03-to-1 ratio; on Nasdaq, a 3.05-to-1 ratio favored decliners.\nThe S&P 500 posted 23 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 34 new highs and 68 new lows.\nOn U.S. exchanges 9.75 billion shares changed hands compared with the 11.41 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699280990,"gmtCreate":1639809327519,"gmtModify":1639809327665,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699280990","repostId":"1109831591","repostType":4,"repost":{"id":"1109831591","pubTimestamp":1639804463,"share":"https://www.laohu8.com/m/news/1109831591?lang=&edition=full","pubTime":"2021-12-18 13:14","market":"us","language":"en","title":"Why Pfizer and Johnson & Johnson Fell on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1109831591","media":"Motley Fool","summary":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnso","content":"<p>What happened</p>\n<p>Two prominent U.S. coronavirus stocks ended the week on a down note.&nbsp;<a href=\"https://laohu8.com/S/PFE\"><b>Pfizer</b></a>&nbsp;and&nbsp;<a href=\"https://laohu8.com/S/JNJ\"><b>Johnson &amp; Johnson</b></a>&nbsp;both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.</p>\n<p><img src=\"https://static.tigerbbs.com/c6a2f152eebbe10f5ab65a99815f461c\" tg-width=\"975\" tg-height=\"637\" width=\"100%\" height=\"auto\"></p>\n<p>So what</p>\n<p><b>Goldman Sachs</b>&nbsp;analyst Chris Shibutani initiated coverage on Pfizer and Johnson &amp; Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.</p>\n<p>Shibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech&nbsp;<b>BioNTech</b>.</p>\n<p>\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.</p>\n<p>As for Johnson &amp; Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.</p>\n<p>\"With [Johnson &amp; Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson &amp; Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.</p>\n<p>Last month, Johnson &amp; Johnson announced plans to spin off its sprawlingconsumer healthcare division.</p>\n<p>Shibutani's price target on Pfizer stock is $51 per share, and that for Johnson &amp; Johnson is $161.</p>\n<p>Now what</p>\n<p>Pfizer and Johnson &amp; Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer and Johnson & Johnson Fell on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer and Johnson & Johnson Fell on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 13:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生","PFE":"辉瑞"},"source_url":"https://www.fool.com/investing/2021/12/17/why-pfizer-and-johnson-johnson-fell-on-friday/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109831591","content_text":"What happened\nTwo prominent U.S. coronavirus stocks ended the week on a down note. Pfizer and Johnson & Johnson both fell on the day by nearly 3%. This followed a prominent investment bank's rather lukewarm take on their current prospects.\n\nSo what\nGoldman Sachs analyst Chris Shibutani initiated coverage on Pfizer and Johnson & Johnson on Friday, tagging both high-profile healthcare industry stocks with neutral recommendations.\nShibutani is concerned with what he considers to be Pfizer's somewhat cloudy future, despite the great success of the Comirnaty coronavirus vaccine it developed with Germanbiotech BioNTech.\n\"Our views on [Pfizer] come down to that we estimate around one-third of its current valuation is attributed to the COVID-19 vaccine and therapeutic [products], and we feel the trajectory for both remains highly uncertain,\" he wrote.\nAs for Johnson & Johnson, the prognosticator feels the stock is also fairly valued. However, he sounded a more optimistic note about the company's potential.\n\"With [Johnson & Johnson] in the midst of transitions across several domains for the organization ... we see possibilities -- even within an organization of [Johnson & Johnson]'s scale and scope -- for additional potentially disruptive opportunities to develop that could reshape the investment thesis, in our view,\" he wrote.\nLast month, Johnson & Johnson announced plans to spin off its sprawlingconsumer healthcare division.\nShibutani's price target on Pfizer stock is $51 per share, and that for Johnson & Johnson is $161.\nNow what\nPfizer and Johnson & Johnson are certainly heading into some uncertain waters -- both with the coronavirus and, in the latter company's case, the apparently looming spinoff. To my mind, though, the two companies have plenty of strength in numerous product areas outside of their respective vaccines, so investors shouldn't be too discouraged by Goldman Sachs' latest evaluations.","news_type":1},"isVote":1,"tweetType":1,"viewCount":911,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607236054,"gmtCreate":1639543096544,"gmtModify":1639543096675,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Yes!","listText":"Yes!","text":"Yes!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607236054","repostId":"1141838908","repostType":4,"repost":{"id":"1141838908","pubTimestamp":1639539097,"share":"https://www.laohu8.com/m/news/1141838908?lang=&edition=full","pubTime":"2021-12-15 11:31","market":"us","language":"en","title":"Google Will Dock Pay, Fire Staff Who Balk at Vaccines, CNBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1141838908","media":"Bloomberg","summary":"Employees have till Jan. 18 to comply with internal policy\nStaff may get fired, CNBC cites Google sa","content":"<ul>\n <li>Employees have till Jan. 18 to comply with internal policy</li>\n <li>Staff may get fired, CNBC cites Google saying in memo</li>\n</ul>\n<p>Google&nbsp;has threatened to reduce pay or even fire staff who fail to comply with internal policies on Covid 19 vaccinations, CNBC&nbsp;reported, citing internal documents.</p>\n<p>The&nbsp;Alphabet Inc.&nbsp;unit warned employees they had till Dec. 3 to declare and prove their vaccination status, or apply for exemptions. Those who hadn’t complied by Jan. 18 will be placed on “paid administrative leave” for 30 days, CNBC&nbsp;said. They could then be put on unpaid leave for up to six months, before finally getting dismissed, it added.</p>\n<p>Like much of the U.S., Silicon Valley is coping with a resurgence in Covid 19 and the new omicron variant, forcing companies to&nbsp;re-evaluate&nbsp;plans to get staff to return to offices. The Biden administration has mandated vaccinations for federal contractors nationwide, but several major U.S. corporations have suspended efforts to comply amid a slew of challenges from states that say the president&nbsp;overstepped&nbsp;his authority in requiring Covid-19 shots.</p>\n<p>Google, which employs more than 150,000 in the country, said it plans to follow Biden’s order. In July, the search giant said it will&nbsp;require&nbsp;all workers returning to work to get vaccinated. Representatives for the company didn’t immediately respond to a request for comment.</p>\n<p>“We expect that almost all roles at Google in the US will fall within the scope of the executive order,” CNBC reported, citing Google’s memo. “Anyone entering a Google building must be fully vaccinated or have an approved accommodation that allows them to work or come onsite,” the company said, adding that “frequent testing is not a valid alternative to vaccination.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google Will Dock Pay, Fire Staff Who Balk at Vaccines, CNBC Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle Will Dock Pay, Fire Staff Who Balk at Vaccines, CNBC Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 11:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-15/google-will-dock-pay-fire-staff-who-balk-at-vaccines-cnbc-says?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Employees have till Jan. 18 to comply with internal policy\nStaff may get fired, CNBC cites Google saying in memo\n\nGoogle has threatened to reduce pay or even fire staff who fail to comply with ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-15/google-will-dock-pay-fire-staff-who-balk-at-vaccines-cnbc-says?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","GOOGL":"谷歌A"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-15/google-will-dock-pay-fire-staff-who-balk-at-vaccines-cnbc-says?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141838908","content_text":"Employees have till Jan. 18 to comply with internal policy\nStaff may get fired, CNBC cites Google saying in memo\n\nGoogle has threatened to reduce pay or even fire staff who fail to comply with internal policies on Covid 19 vaccinations, CNBC reported, citing internal documents.\nThe Alphabet Inc. unit warned employees they had till Dec. 3 to declare and prove their vaccination status, or apply for exemptions. Those who hadn’t complied by Jan. 18 will be placed on “paid administrative leave” for 30 days, CNBC said. They could then be put on unpaid leave for up to six months, before finally getting dismissed, it added.\nLike much of the U.S., Silicon Valley is coping with a resurgence in Covid 19 and the new omicron variant, forcing companies to re-evaluate plans to get staff to return to offices. The Biden administration has mandated vaccinations for federal contractors nationwide, but several major U.S. corporations have suspended efforts to comply amid a slew of challenges from states that say the president overstepped his authority in requiring Covid-19 shots.\nGoogle, which employs more than 150,000 in the country, said it plans to follow Biden’s order. In July, the search giant said it will require all workers returning to work to get vaccinated. Representatives for the company didn’t immediately respond to a request for comment.\n“We expect that almost all roles at Google in the US will fall within the scope of the executive order,” CNBC reported, citing Google’s memo. “Anyone entering a Google building must be fully vaccinated or have an approved accommodation that allows them to work or come onsite,” the company said, adding that “frequent testing is not a valid alternative to vaccination.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":414,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607231414,"gmtCreate":1639543026343,"gmtModify":1639543026517,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607231414","repostId":"1156446659","repostType":4,"repost":{"id":"1156446659","pubTimestamp":1639540344,"share":"https://www.laohu8.com/m/news/1156446659?lang=&edition=full","pubTime":"2021-12-15 11:52","market":"us","language":"en","title":"Warren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap","url":"https://stock-news.laohu8.com/highlight/detail?id=1156446659","media":"Business Insider","summary":"Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Frid","content":"<ul>\n <li><b>Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.</b></li>\n <li><b>That makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $649 billion market capitalization.</b></li>\n <li><b>Warren Buffett started to build Berkshire's position in Apple in 2016 and added to it up until mid-2018.</b></li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4348b5dc216a2be5e154d22e356336b9\" tg-width=\"790\" tg-height=\"395\" width=\"100%\" height=\"auto\"><span>SCOTT MORGAN/REUTERS</span></p>\n<p>Warren Buffett is known for concentrating his investments to build generational wealth, and&nbsp;Berkshire Hathaway's&nbsp;stake in&nbsp;Apple&nbsp;is no better example of that investment practice.</p>\n<p>Berkshire's 887.1 million shares in the iPhone maker swelled to a record value of $159 billion on Friday, a 342% increase from its&nbsp;original cost basis of about $36 billion.That means Apple is now worth more than half of Berkshire's $293 billion equity portfolio, based on data from its third-quarter 13F filing.</p>\n<p>And assuming Berkshire hasn't trimmed its Apple position since September 30, the equity stake now represents about a quarter of Berkshire Hathaway's $649 billion market capitalization.</p>\n<p>What also makes Buffett's concentration in Apple notable is that it didn't take&nbsp;decades to compound&nbsp;like most successful investments managed by Buffett. Instead, it's only been five years since Berkshire began to build its stake in Apple.</p>\n<p>The conglomerate first purchased Apple shares in 2016 and continued buying them until mid-2018, when the position topped 1 billion shares after adjusting for a 4-for-1 stock split in 2020. Buffett has&nbsp;trimmed Berkshire's position in Apple&nbsp;by about 12% since initially building the stake.</p>\n<p>Barring any changes since the most recent 13F filing, Berkshire's stock portfolio would be up 13.9% quarter-to-date, according to&nbsp;an analysis by Bespoke.Much of that gain has been driven by Apple's quarter-to-date gain of more than 20%.</p>\n<p>Year-to-date, Apple is up 31%, compared to Berkshire Hathaway's return of 26%. Apple's stock price was less than&nbsp;$1.00 away from hitting a $3 trillion valuation on Monday.</p>\n<p>Berkshire's three largest positions after Apple are&nbsp;Bank of America,American Express, and&nbsp;Coca-Cola, which make up a combined 30% of the equity portfolio's value. And Berkshire is still sitting on about $150 billion in cash that it has yet to put to work.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett has grown Berkshire Hathaway's Apple stake to 50% of its entire equity portfolio and nearly a quarter of its $649 billion market cap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 11:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12><strong>Business Insider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.\nThat makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $...</p>\n\n<a href=\"https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","BRK.A":"伯克希尔","BRK.B":"伯克希尔B"},"source_url":"https://markets.businessinsider.com/news/stocks/warren-buffett-apple-stake-half-berkshire-hathaway-equity-portfolio-concentration-2021-12","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156446659","content_text":"Berkshire Hathaway's Apple holdings of 887 million shares swelled to a value of $159 billion on Friday.\nThat makes the stake worth half of Berkshire's entire equity portfolio, and almost 25% of its $649 billion market capitalization.\nWarren Buffett started to build Berkshire's position in Apple in 2016 and added to it up until mid-2018.\n\nSCOTT MORGAN/REUTERS\nWarren Buffett is known for concentrating his investments to build generational wealth, and Berkshire Hathaway's stake in Apple is no better example of that investment practice.\nBerkshire's 887.1 million shares in the iPhone maker swelled to a record value of $159 billion on Friday, a 342% increase from its original cost basis of about $36 billion.That means Apple is now worth more than half of Berkshire's $293 billion equity portfolio, based on data from its third-quarter 13F filing.\nAnd assuming Berkshire hasn't trimmed its Apple position since September 30, the equity stake now represents about a quarter of Berkshire Hathaway's $649 billion market capitalization.\nWhat also makes Buffett's concentration in Apple notable is that it didn't take decades to compound like most successful investments managed by Buffett. Instead, it's only been five years since Berkshire began to build its stake in Apple.\nThe conglomerate first purchased Apple shares in 2016 and continued buying them until mid-2018, when the position topped 1 billion shares after adjusting for a 4-for-1 stock split in 2020. Buffett has trimmed Berkshire's position in Apple by about 12% since initially building the stake.\nBarring any changes since the most recent 13F filing, Berkshire's stock portfolio would be up 13.9% quarter-to-date, according to an analysis by Bespoke.Much of that gain has been driven by Apple's quarter-to-date gain of more than 20%.\nYear-to-date, Apple is up 31%, compared to Berkshire Hathaway's return of 26%. Apple's stock price was less than $1.00 away from hitting a $3 trillion valuation on Monday.\nBerkshire's three largest positions after Apple are Bank of America,American Express, and Coca-Cola, which make up a combined 30% of the equity portfolio's value. And Berkshire is still sitting on about $150 billion in cash that it has yet to put to work.","news_type":1},"isVote":1,"tweetType":1,"viewCount":394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607385366,"gmtCreate":1639490417552,"gmtModify":1639490417679,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607385366","repostId":"1192557604","repostType":4,"isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877243995,"gmtCreate":1637938529515,"gmtModify":1637938529515,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/877243995","repostId":"1127856678","repostType":2,"repost":{"id":"1127856678","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637937010,"share":"https://www.laohu8.com/m/news/1127856678?lang=&edition=full","pubTime":"2021-11-26 22:30","market":"us","language":"en","title":"Dow drops 800 points as new Covid variant sparks market sell-off","url":"https://stock-news.laohu8.com/highlight/detail?id=1127856678","media":"Tiger Newspress","summary":"U.S. stock dropped on Friday on renewed Covid fears over a new variant found in South Africa.\nThe Do","content":"<p>U.S. stock dropped on Friday on&nbsp;renewed Covid fears over a new variant found in South Africa.</p>\n<p>The Dow Jones Industrial Average dropped 800 points, or more than 2%, while the S&amp;P 500 and Nasdaq Composite slid 1.4% and 0.9%, respectively. Friday is a shortened trading day because of the Thanksgiving holiday with U.S. markets closing at 1 p.m. ET.</p>\n<p>Anew coronavirus variant has been discovered in South Africa, leading to an emergency session of the World Health Organization. Scientists say the new B.1.1.529 strain a concern, because it harbors a large number of mutations found in other variants — including the fast-spreading Delta variant that exploded over much of the summer — and it seems to be rapidly spreading.</p>\n<p>While there's no evidence yet, health officials are worried that the mutating variant could dilute or resist the efficacy of vaccines.</p>\n<p>\"It goes without saying that it’s still too early to say exactly how big a threat the new B.1.1.529 strain poses to the global economy,\" Neil Shearing, Group Chief Economist at Capital Economics, said in a note.</p>\n<p>Still, \"the lesson from the past couple of years is that it’s the restrictions that are imposed in response to the virus – rather than the virus itself – that causes the bulk of the economic damage. So, the key question is how governments will respond in the event that the B.1.1.529 strain spreads,\" Shearling wrote.</p>\n<p>\"That in turn will hinge on the extent to which it escapes the vaccines and, importantly, causes strains in national healthcare systems,\" he added — underscoring that governments in the U.S. and U.K. had taken a \"learn to live with the virus\" approach, and thus are far less likely than other regions to impose new restrictions.</p>\n<p>Meanwhile, BioNTech (BNTX) said on Friday&nbsp;it expects more data on the new coronavirus variant in South Africa within two weeks&nbsp;to help its shots should be reworked.</p>\n<p>Oil prices also swooned, with U.S. crude futures down 6.2% to $73.57 per barrel on perceived fears of falling demand amid the new variant. Bond yields have also fallen as the market's inflation fears temporarily gave way to the desire for safe-haven assets. The yield on the benchmark 10-year U.S. Treasury note was down to 1.53% after closing at 1.63% on Wednesday.</p>\n<p>There is no major economic releases scheduled for Friday. The stock market will close at 1 p.m. ET on Friday due to the holiday weekend.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow drops 800 points as new Covid variant sparks market sell-off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow drops 800 points as new Covid variant sparks market sell-off\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock dropped on Friday on&nbsp;renewed Covid fears over a new variant found in South Africa.</p>\n<p>The Dow Jones Industrial Average dropped 800 points, or more than 2%, while the S&amp;P 500 and Nasdaq Composite slid 1.4% and 0.9%, respectively. Friday is a shortened trading day because of the Thanksgiving holiday with U.S. markets closing at 1 p.m. ET.</p>\n<p>Anew coronavirus variant has been discovered in South Africa, leading to an emergency session of the World Health Organization. Scientists say the new B.1.1.529 strain a concern, because it harbors a large number of mutations found in other variants — including the fast-spreading Delta variant that exploded over much of the summer — and it seems to be rapidly spreading.</p>\n<p>While there's no evidence yet, health officials are worried that the mutating variant could dilute or resist the efficacy of vaccines.</p>\n<p>\"It goes without saying that it’s still too early to say exactly how big a threat the new B.1.1.529 strain poses to the global economy,\" Neil Shearing, Group Chief Economist at Capital Economics, said in a note.</p>\n<p>Still, \"the lesson from the past couple of years is that it’s the restrictions that are imposed in response to the virus – rather than the virus itself – that causes the bulk of the economic damage. So, the key question is how governments will respond in the event that the B.1.1.529 strain spreads,\" Shearling wrote.</p>\n<p>\"That in turn will hinge on the extent to which it escapes the vaccines and, importantly, causes strains in national healthcare systems,\" he added — underscoring that governments in the U.S. and U.K. had taken a \"learn to live with the virus\" approach, and thus are far less likely than other regions to impose new restrictions.</p>\n<p>Meanwhile, BioNTech (BNTX) said on Friday&nbsp;it expects more data on the new coronavirus variant in South Africa within two weeks&nbsp;to help its shots should be reworked.</p>\n<p>Oil prices also swooned, with U.S. crude futures down 6.2% to $73.57 per barrel on perceived fears of falling demand amid the new variant. Bond yields have also fallen as the market's inflation fears temporarily gave way to the desire for safe-haven assets. The yield on the benchmark 10-year U.S. Treasury note was down to 1.53% after closing at 1.63% on Wednesday.</p>\n<p>There is no major economic releases scheduled for Friday. The stock market will close at 1 p.m. ET on Friday due to the holiday weekend.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127856678","content_text":"U.S. stock dropped on Friday on renewed Covid fears over a new variant found in South Africa.\nThe Dow Jones Industrial Average dropped 800 points, or more than 2%, while the S&P 500 and Nasdaq Composite slid 1.4% and 0.9%, respectively. Friday is a shortened trading day because of the Thanksgiving holiday with U.S. markets closing at 1 p.m. ET.\nAnew coronavirus variant has been discovered in South Africa, leading to an emergency session of the World Health Organization. Scientists say the new B.1.1.529 strain a concern, because it harbors a large number of mutations found in other variants — including the fast-spreading Delta variant that exploded over much of the summer — and it seems to be rapidly spreading.\nWhile there's no evidence yet, health officials are worried that the mutating variant could dilute or resist the efficacy of vaccines.\n\"It goes without saying that it’s still too early to say exactly how big a threat the new B.1.1.529 strain poses to the global economy,\" Neil Shearing, Group Chief Economist at Capital Economics, said in a note.\nStill, \"the lesson from the past couple of years is that it’s the restrictions that are imposed in response to the virus – rather than the virus itself – that causes the bulk of the economic damage. So, the key question is how governments will respond in the event that the B.1.1.529 strain spreads,\" Shearling wrote.\n\"That in turn will hinge on the extent to which it escapes the vaccines and, importantly, causes strains in national healthcare systems,\" he added — underscoring that governments in the U.S. and U.K. had taken a \"learn to live with the virus\" approach, and thus are far less likely than other regions to impose new restrictions.\nMeanwhile, BioNTech (BNTX) said on Friday it expects more data on the new coronavirus variant in South Africa within two weeks to help its shots should be reworked.\nOil prices also swooned, with U.S. crude futures down 6.2% to $73.57 per barrel on perceived fears of falling demand amid the new variant. Bond yields have also fallen as the market's inflation fears temporarily gave way to the desire for safe-haven assets. The yield on the benchmark 10-year U.S. Treasury note was down to 1.53% after closing at 1.63% on Wednesday.\nThere is no major economic releases scheduled for Friday. The stock market will close at 1 p.m. ET on Friday due to the holiday weekend.","news_type":1},"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699217491,"gmtCreate":1639809192669,"gmtModify":1639809192822,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699217491","repostId":"1116106959","repostType":4,"repost":{"id":"1116106959","pubTimestamp":1639785552,"share":"https://www.laohu8.com/m/news/1116106959?lang=&edition=full","pubTime":"2021-12-18 07:59","market":"us","language":"en","title":"Wall Street ends down after mostly negative week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116106959","media":"Reuters","summary":" - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S","content":"<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.</p>\n<p>All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.</p>\n<p>Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&amp;P 500 and Nasdaq.</p>\n<p>The S&amp;P 500 growth index lost 0.7% and the value index declined 1.4%.</p>\n<p>All of the 11 major S&amp;P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.</p>\n<p>Adding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.</p>\n<p>Traders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.</p>\n<p>\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"</p>\n<p>Heavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&amp;P 500 index gained around 23% in the same period.</p>\n<p>In Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&amp;P 500 lost 1.03% to 4,620.64.</p>\n<p>The Nasdaq Composite dropped 0.07% to 15,169.68.</p>\n<p>On a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.</p>\n<p>With options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.</p>\n<p>For the week, the S&amp;P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.</p>\n<p>In Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.</p>\n<p>FedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends down after mostly negative week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends down after mostly negative week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-18 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-street-ends-212015460.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116106959","content_text":"(Reuters) - Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.\nAll three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.\nNvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.\nThe S&P 500 growth index lost 0.7% and the value index declined 1.4%.\nAll of the 11 major S&P 500 sector indexes fell, with financials leading the way down with a 2.3% drop. Energy lost 2.2%.\nAdding to uncertainty, Pfizer said on Friday the pandemic could extend through next year. European countries geared up for further travel and social restrictions and a study warned that the rapidly spreading Omicron coronavirus variant was five times more likely to reinfect people than its predecessor, Delta.\nTraders also pointed to year-end tax selling and the simultaneous expiration of stock options, stock index futures and index options contracts - known as triple witching - as potential causes for volatility.\n\"It's a big options expiration day,\" said Joe Saluzzi, co-manager of trading at Themis Trading in Chatham, New Jersey. \"And now you draw on top of that some Omicron, and you've got volatility, and I think it creates a lot of uncertainty amongst investors. Where are you going to position for the end of the year?\"\nHeavyweight growth stocks including Nvidia and Microsoft have outperformed the broader market in 2021, while the Philadelphia SE Semiconductor index has surged about 35%. The benchmark S&P 500 index gained around 23% in the same period.\nIn Friday's session, the Dow Jones Industrial Average fell 1.48% to end at 35,365.44 points, while the S&P 500 lost 1.03% to 4,620.64.\nThe Nasdaq Composite dropped 0.07% to 15,169.68.\nOn a positive note, the small-cap Russell 2000 index rallied 1% after having fallen more than 10% from a record high in early November.\nWith options expiring, volume on U.S. exchanges jumped to 16.6 billion shares, far above the 11.9 billion average over the last 20 trading days.\nFor the week, the S&P 500 fell 1.9%, the Dow lost 1.7% and the Nasdaq declined 2.9%.\nIn Friday's session, Oracle tumbled 6.4% after the Wall Street Journal reported the enterprise software maker is in talks to buy electronic medical records company Cerner in a deal that could be valued at $30 billion. Shares of Cerner surged 12.9%.\nFedEx Corp rose almost 5% after the delivery firm reinstated its original fiscal 2022 forecast on Thursday, even as persistent labor woes chipped away profits.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.50-to-1 ratio; on Nasdaq, a 1.16-to-1 ratio favored advancers.\nThe S&P 500 posted 22 new 52-week highs and seven new lows; the Nasdaq Composite recorded 28 new highs and 341 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":990,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690034624,"gmtCreate":1639612881664,"gmtModify":1639612881802,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Buy?","listText":"Buy?","text":"Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690034624","repostId":"1169241179","repostType":4,"repost":{"id":"1169241179","pubTimestamp":1639611934,"share":"https://www.laohu8.com/m/news/1169241179?lang=&edition=full","pubTime":"2021-12-16 07:45","market":"us","language":"en","title":"Roku Stock Tumbled. Some See a Buying Opportunity.","url":"https://stock-news.laohu8.com/highlight/detail?id=1169241179","media":"Barrons","summary":"Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its","content":"<p>Roku&nbsp;stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with&nbsp;Universal Electronics,and an analyst price-target cut. Some bullish analysts downplayed the patent announcement, calling the drop a buying opportunity in the maker of streaming devices.</p>\n<p>Roku (ticker: ROKU) stock fell 7.9% to close at $203.94 on Wednesday, its lowest close since $203.49 on Nov. 3, 2020. The stock is down 58% from July 26, when shares closed at a record $479.50. The Wednesday drop came as remarks from the Fed sent the tech-heavy&nbsp;Nasdaq Composite index&nbsp;up more than 2%, and the&nbsp;S&amp;P 500 index&nbsp;up 1.6%.</p>\n<p>Investors were caught off guard Wednesday by an announcement by Universal Electronics (UEIC), referring to the public release of the International Trade Commission’s decision in a patent-infringement case, related to technology in certain Roku remote controls. The case was decided in November.</p>\n<p>“We brought this action to protect our highly innovative intellectual property from unauthorized use by Roku, and we are gratified that the ITC recognized Roku’s infringement and ordered it halted,” Universal Electronics said in the news release.</p>\n<p>Roku said in a statement that there were no new developments in the case. “Based on the ITC’s ruling, we do not anticipate any disruption in&nbsp;Roku’s ability to continue to import products,” Roku said.</p>\n<p>Oppenheimer analyst Jason Helfstein noted that the news release may have weighed on Roku stock. He called the dip a buying opportunity, pointing to his bullish outlook for connected-television advertising spending. Helfstein rates Roku stock at Outperform with a $400 price target.</p>\n<p>Aside from selling streaming devices, the company makes the lion’s share of its sales from certain advertisements and subscriptions made on its platform. Shares have fallen in recent months amid lower expectations for growth as the pandemic’s reopening unfolds.</p>\n<p>Also on Wednesday, Morgan Stanley analyst Benjamin Swinburne, who has an Underweight rating on Roku stock, slashed his price target to $190 from $295. He does acknowledge that the stock’s risk-reward setup is less skewed toward risk following recent declines in the share price.</p>\n<p>“We believe the market is underestimating the competition on Platform active accounts in the U.S., as well as the time it takes for international expansion to scale,” Swinburne wrote. “Active account growth has benefited strongly in the U.S. from share gains at TCL, and sustained growth will require additional share gains or major new smart TV partners.”</p>\n<p>Other analysts were more upbeat. Benchmark analyst Daniel Kurnos called the stock’s reaction overstated in a Wednesday note. He has a $525 target with a Buy rating on the stock.</p>\n<p>J.P.Morgan analyst Doug Anmuth called Roku the leading streaming platform in the U.S. by hours streamed, though he did cut his target to $315 from $435.</p>\n<p>“Our bull thesis is largely driven by what we believe to be Roku’s significant advertising opportunity, with streaming accounting for about 42% of TV viewing time for 18-49 year olds in the U.S., but only an estimated about 15% of TV ad budgets,” he wrote.</p>\n<p>He expects outsize growth in Roku’s advertisements business to drive revenue growth north of 25% year over year through 2024, with profitability improving as the platform segment stabilizes and grows as a percentage of revenue. Anmuth rates Roku stock at Outperform.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku Stock Tumbled. Some See a Buying Opportunity.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku Stock Tumbled. Some See a Buying Opportunity.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with Universal Electronics,and an analyst price-target cut. Some bullish analysts ...</p>\n\n<a href=\"https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ROKU":"Roku Inc"},"source_url":"https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169241179","content_text":"Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with Universal Electronics,and an analyst price-target cut. Some bullish analysts downplayed the patent announcement, calling the drop a buying opportunity in the maker of streaming devices.\nRoku (ticker: ROKU) stock fell 7.9% to close at $203.94 on Wednesday, its lowest close since $203.49 on Nov. 3, 2020. The stock is down 58% from July 26, when shares closed at a record $479.50. The Wednesday drop came as remarks from the Fed sent the tech-heavy Nasdaq Composite index up more than 2%, and the S&P 500 index up 1.6%.\nInvestors were caught off guard Wednesday by an announcement by Universal Electronics (UEIC), referring to the public release of the International Trade Commission’s decision in a patent-infringement case, related to technology in certain Roku remote controls. The case was decided in November.\n“We brought this action to protect our highly innovative intellectual property from unauthorized use by Roku, and we are gratified that the ITC recognized Roku’s infringement and ordered it halted,” Universal Electronics said in the news release.\nRoku said in a statement that there were no new developments in the case. “Based on the ITC’s ruling, we do not anticipate any disruption in Roku’s ability to continue to import products,” Roku said.\nOppenheimer analyst Jason Helfstein noted that the news release may have weighed on Roku stock. He called the dip a buying opportunity, pointing to his bullish outlook for connected-television advertising spending. Helfstein rates Roku stock at Outperform with a $400 price target.\nAside from selling streaming devices, the company makes the lion’s share of its sales from certain advertisements and subscriptions made on its platform. Shares have fallen in recent months amid lower expectations for growth as the pandemic’s reopening unfolds.\nAlso on Wednesday, Morgan Stanley analyst Benjamin Swinburne, who has an Underweight rating on Roku stock, slashed his price target to $190 from $295. He does acknowledge that the stock’s risk-reward setup is less skewed toward risk following recent declines in the share price.\n“We believe the market is underestimating the competition on Platform active accounts in the U.S., as well as the time it takes for international expansion to scale,” Swinburne wrote. “Active account growth has benefited strongly in the U.S. from share gains at TCL, and sustained growth will require additional share gains or major new smart TV partners.”\nOther analysts were more upbeat. Benchmark analyst Daniel Kurnos called the stock’s reaction overstated in a Wednesday note. He has a $525 target with a Buy rating on the stock.\nJ.P.Morgan analyst Doug Anmuth called Roku the leading streaming platform in the U.S. by hours streamed, though he did cut his target to $315 from $435.\n“Our bull thesis is largely driven by what we believe to be Roku’s significant advertising opportunity, with streaming accounting for about 42% of TV viewing time for 18-49 year olds in the U.S., but only an estimated about 15% of TV ad budgets,” he wrote.\nHe expects outsize growth in Roku’s advertisements business to drive revenue growth north of 25% year over year through 2024, with profitability improving as the platform segment stabilizes and grows as a percentage of revenue. Anmuth rates Roku stock at Outperform.","news_type":1},"isVote":1,"tweetType":1,"viewCount":395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604566300,"gmtCreate":1639413578821,"gmtModify":1639413578974,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604566300","repostId":"1171271872","repostType":4,"repost":{"id":"1171271872","pubTimestamp":1639348466,"share":"https://www.laohu8.com/m/news/1171271872?lang=&edition=full","pubTime":"2021-12-13 06:34","market":"us","language":"en","title":"Rivian,Adobe,FedEx,Lennar,Campbell Soup,and Other Stocks to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1171271872","media":"Barrons","summary":"The main event for investors this week will be the Federal Reserve’s rate-setting committee’s last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential announcement of plans to accelerate monthly asset purchase tapering.The Federal Open Market Committee’s two-day meeting takes place on Tuesday and Wednesday.Earnings reports this week are few, but will include Campbell Soup on Tuesday;Lennar,Accenture,FedEx,Rivian Automotive, and Adobe on Thursday; and","content":"<p>The main event for investors this week will be the Federal Reserve’s rate-setting committee’s&nbsp;last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential announcement of plans to accelerate monthly asset purchase tapering.</p>\n<p>The Federal Open Market Committee’s two-day meeting takes place on Tuesday and Wednesday.</p>\n<p>Earnings reports this week are few, but will include&nbsp;Campbell Soup&nbsp;on Tuesday;Lennar,Accenture,FedEx,Rivian&nbsp;Automotive, and&nbsp;Adobe&nbsp;on Thursday; and&nbsp;Darden Restaurants&nbsp;on Friday.</p>\n<p>Economic data coming out this week includes the Bureau of Labor Statistics’ producer price index for November on Tuesday. Economists expect a 0.55% month-over-month rise for the headline index and a 0.4% gain for the core PPI. Those would both roughly match October’s pace of producer inflation.</p>\n<p>Other data releases include the National Federation of Independent Businesses’ sentiment&nbsp;index on Tuesday, November retail-sales spending from the Census Bureau on Wednesday, and the November housing starts on Thursday.</p>\n<p><b>Monday 12/13</b></p>\n<p>J.Jill&nbsp;and&nbsp;PHX Minerals&nbsp;host earnings conference calls.</p>\n<p><b>Tuesday 12/14</b></p>\n<p>Campbell Soup, Barnes Group, and&nbsp;Avaya Holdings&nbsp;host investor days.</p>\n<p><b>The Bureau of Labor</b>&nbsp;Statistics releases the producer price index for November. Consensus estimate is for a 0.55% month-over-month rise, and for the core PPI, which excludes food and energy, to gain 0.4%. This compares with increases of 0.6% and 0.4%, respectively, in October.</p>\n<p><b>The National Federation</b>&nbsp;of Independent Businesses reports its index, which surveys about 5,000 small-business owners across the country, for November. Expectations call for a reading of 98.3, compared with 98.2 in October.</p>\n<p><b>Wednesday 12/15</b></p>\n<p><b>The Federal Open Market Committee</b> concludes its two-day meeting, when policy makers will discuss accelerating the timetable for tapering monthly securities purchases.</p>\n<p><b>The BLS reports</b> export and import price data for November. Expectations are for a 0.5% month-over-month rise in export prices, while import prices are seen increasing 0.5%. This compares with gains of 1.5% and 1.2%, respectively, in October.</p>\n<p><b>The National Association</b> of Home Builders releases its NAHB/Wells Fargo Housing Market Index for December. Consensus estimate is for an 84 reading, compared with an 83 reading in November. The index peaked at 90 late last year, and home builders remain bullish on the housing market.</p>\n<p><b>The Census Bureau</b> reports on retail-sales spending for November. Expectations are for a seasonally adjusted 0.7% month-over-month increase in retail sales, compared with a 1.7% rise in October. Excluding autos, spending is seen rising 0.8%, compared with 1.7% in the previous period.</p>\n<p><b>Thursday 12/16</b></p>\n<p>Heico,Lennar, Accenture, FedEx, Jabil, Adobe, Rivian Automotive, and Nordson are among companies hosting earnings conference calls.</p>\n<p><b>The Census Bureau</b>releases its New Residential Construction report for November. The seasonally adjusted annual rate of housing starts is expected to be 1.563 million units, compared with 1.52 million in October. A housing start is counted when excavation begins on a home. Permits issued for new-home construction are expected to be 1.655 million, compared with 1.653 million in October.</p>\n<p><b>The Bank of England</b> announces its interest-rate decision and publishes the minutes of the meeting.</p>\n<p><b>The Federal Reserve</b> releases industrial production data for November. Economists are looking for a 0.6% rise, after a 1.6% increase in October. Capacity utilization is expected at 76.8, roughly in line with October’s 76.4%.</p>\n<p><b>Friday 12/17</b></p>\n<p>Steelcase,Darden Restaurants, and&nbsp;Quanex Building Products&nbsp;host earnings conference calls.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rivian,Adobe,FedEx,Lennar,Campbell Soup,and Other Stocks to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRivian,Adobe,FedEx,Lennar,Campbell Soup,and Other Stocks to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 06:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stocks-to-watch-this-week-fedex-rivian-lennar-campbell-adobe-51639330550?mod=hp_LEAD_3><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The main event for investors this week will be the Federal Reserve’s rate-setting committee’s last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential ...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-to-watch-this-week-fedex-rivian-lennar-campbell-adobe-51639330550?mod=hp_LEAD_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc.","CPB":"金宝汤","ACN":"埃森哲",".SPX":"S&P 500 Index","JILL":"J.Jill Inc.","HEI":"海科航空","LEN":"莱纳建筑公司","PHX":"潘汉德尔油气",".DJI":"道琼斯","ADBE":"Adobe","SCS":"Steelcase Inc.","DRI":"达登饭店",".IXIC":"NASDAQ Composite","FDX":"联邦快递"},"source_url":"https://www.barrons.com/articles/stocks-to-watch-this-week-fedex-rivian-lennar-campbell-adobe-51639330550?mod=hp_LEAD_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171271872","content_text":"The main event for investors this week will be the Federal Reserve’s rate-setting committee’s last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential announcement of plans to accelerate monthly asset purchase tapering.\nThe Federal Open Market Committee’s two-day meeting takes place on Tuesday and Wednesday.\nEarnings reports this week are few, but will include Campbell Soup on Tuesday;Lennar,Accenture,FedEx,Rivian Automotive, and Adobe on Thursday; and Darden Restaurants on Friday.\nEconomic data coming out this week includes the Bureau of Labor Statistics’ producer price index for November on Tuesday. Economists expect a 0.55% month-over-month rise for the headline index and a 0.4% gain for the core PPI. Those would both roughly match October’s pace of producer inflation.\nOther data releases include the National Federation of Independent Businesses’ sentiment index on Tuesday, November retail-sales spending from the Census Bureau on Wednesday, and the November housing starts on Thursday.\nMonday 12/13\nJ.Jill and PHX Minerals host earnings conference calls.\nTuesday 12/14\nCampbell Soup, Barnes Group, and Avaya Holdings host investor days.\nThe Bureau of Labor Statistics releases the producer price index for November. Consensus estimate is for a 0.55% month-over-month rise, and for the core PPI, which excludes food and energy, to gain 0.4%. This compares with increases of 0.6% and 0.4%, respectively, in October.\nThe National Federation of Independent Businesses reports its index, which surveys about 5,000 small-business owners across the country, for November. Expectations call for a reading of 98.3, compared with 98.2 in October.\nWednesday 12/15\nThe Federal Open Market Committee concludes its two-day meeting, when policy makers will discuss accelerating the timetable for tapering monthly securities purchases.\nThe BLS reports export and import price data for November. Expectations are for a 0.5% month-over-month rise in export prices, while import prices are seen increasing 0.5%. This compares with gains of 1.5% and 1.2%, respectively, in October.\nThe National Association of Home Builders releases its NAHB/Wells Fargo Housing Market Index for December. Consensus estimate is for an 84 reading, compared with an 83 reading in November. The index peaked at 90 late last year, and home builders remain bullish on the housing market.\nThe Census Bureau reports on retail-sales spending for November. Expectations are for a seasonally adjusted 0.7% month-over-month increase in retail sales, compared with a 1.7% rise in October. Excluding autos, spending is seen rising 0.8%, compared with 1.7% in the previous period.\nThursday 12/16\nHeico,Lennar, Accenture, FedEx, Jabil, Adobe, Rivian Automotive, and Nordson are among companies hosting earnings conference calls.\nThe Census Bureaureleases its New Residential Construction report for November. The seasonally adjusted annual rate of housing starts is expected to be 1.563 million units, compared with 1.52 million in October. A housing start is counted when excavation begins on a home. Permits issued for new-home construction are expected to be 1.655 million, compared with 1.653 million in October.\nThe Bank of England announces its interest-rate decision and publishes the minutes of the meeting.\nThe Federal Reserve releases industrial production data for November. Economists are looking for a 0.6% rise, after a 1.6% increase in October. Capacity utilization is expected at 76.8, roughly in line with October’s 76.4%.\nFriday 12/17\nSteelcase,Darden Restaurants, and Quanex Building Products host earnings conference calls.","news_type":1},"isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606724373,"gmtCreate":1638930820677,"gmtModify":1638930820756,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Oh like","listText":"Oh like","text":"Oh like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606724373","repostId":"2189719656","repostType":4,"repost":{"id":"2189719656","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638914193,"share":"https://www.laohu8.com/m/news/2189719656?lang=&edition=full","pubTime":"2021-12-08 05:56","market":"us","language":"en","title":"Wall Street closes higher with Nasdaq boosted by tech rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2189719656","media":"Reuters","summary":"Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some ","content":"<p>Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.</p>\n<p>Intel's announcement of plans to take its self-driving car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.</p>\n<p>The Philadelphia SE Semiconductor index closed up 4.97% after hitting a near <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month low on Tuesday.</p>\n<p>Investors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.</p>\n<p>Before market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.</p>\n<p>That news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.</p>\n<p>\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Michael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"</p>\n<p>He also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.</p>\n<p>\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"</p>\n<p>The Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&amp;P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.</p>\n<p>The CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.</p>\n<p>All of the 11 major S&amp;P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.</p>\n<p>The S&amp;P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&amp;P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.</p>\n<p>In the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.</p>\n<p>Vir Biotechnology closed up 11.9%.</p>\n<p>Merck &amp; Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.</p>\n<p>On U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes higher with Nasdaq boosted by tech rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes higher with Nasdaq boosted by tech rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-08 05:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.</p>\n<p>Intel's announcement of plans to take its self-driving car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.</p>\n<p>The Philadelphia SE Semiconductor index closed up 4.97% after hitting a near <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month low on Tuesday.</p>\n<p>Investors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.</p>\n<p>Before market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.</p>\n<p>That news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.</p>\n<p>\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Michael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"</p>\n<p>He also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.</p>\n<p>\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"</p>\n<p>The Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&amp;P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.</p>\n<p>The CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.</p>\n<p>All of the 11 major S&amp;P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.</p>\n<p>The S&amp;P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&amp;P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.</p>\n<p>In the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.</p>\n<p>Vir Biotechnology closed up 11.9%.</p>\n<p>Merck &amp; Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.</p>\n<p>On U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189719656","content_text":"Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.\nIntel's announcement of plans to take its self-driving car unit Mobileye public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.\nThe Philadelphia SE Semiconductor index closed up 4.97% after hitting a near one-month low on Tuesday.\nInvestors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.\nBefore market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.\nThat news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.\n\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.\nMichael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"\nHe also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.\n\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"\nThe Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.\nThe CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.\nAll of the 11 major S&P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.\nThe S&P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.\nIn the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.\nVir Biotechnology closed up 11.9%.\nMerck & Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.\nThe S&P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.\nOn U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608962505,"gmtCreate":1638598639642,"gmtModify":1638598639735,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Buy?&nbsp;","listText":"Buy?&nbsp;","text":"Buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608962505","repostId":"2188787815","repostType":4,"repost":{"id":"2188787815","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638583020,"share":"https://www.laohu8.com/m/news/2188787815?lang=&edition=full","pubTime":"2021-12-04 09:57","market":"us","language":"en","title":"Marvell will be 'in the same camp' as AMD, Nvidia after 'one of the best' semiconductor earnings calls","url":"https://stock-news.laohu8.com/highlight/detail?id=2188787815","media":"Dow Jones","summary":"Stock jumps more than 17%, its best day since 2008, as analysts describe chip maker's earnings as 'w","content":"<p>Stock jumps more than 17%, its best day since 2008, as analysts describe chip maker's earnings as 'watershed quarter'</p>\n<p>Shares of Marvell Technology Inc. experienced their best trading day in 13 years after an earnings report that led analysts to predict the chip maker's ascension into the top tier of hot semiconductor stocks.</p>\n<p>Marvell shares <a href=\"https://laohu8.com/S/MRVL\">$(MRVL)$</a> increased 17.7% Friday following the company's fiscal third-quarter earnings report, which saw Marvell top expectations for its latest quarter, issue an upbeat forecast for the current period, and offer encouraging longer-term commentary. The stock posted its largest single-day percentage gain since Dec. 3, 2008, when it rose 20.4%.</p>\n<p>Chief Financial Officer Jean Hu said on the earnings call late Thursday that she expects \"continued strong demand across our end markets and improvement in supply to drive our top line revenue growth above 30% in fiscal 2023.\" That projection generated enthusiasm, as did Marvell's January-quarter revenue forecast that implied upwards of 60% growth.</p>\n<p>The company's earnings call could have been \"one of the best (if not the best) semi conf[erence] calls I have listened to in quite some time,\" wrote Mizuho desk-based analyst Jordan Klein in a note affiliated with Mizuho's sales operations and not its research team. \"In fact, it was a GAME-CHANGER for investors and in my view squarely positions Marvell as a best-in-class GROWTH SEMI into CY22,\" he continued.</p>\n<p>Marvell \"will be in the same camp now\" as Advanced Micro Devices Inc. <a href=\"https://laohu8.com/S/AMD\">$(AMD)$</a> and Nvidia Corp. <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, he argued, amid the company's cheery growth projections and likely expectations among the bull camp for $4 a share in annual earnings power within a few years. The company has a \"clear line of sight given a backlog full of design wins that has basically locked in that growth rate\" on the revenue line, he said in his note.</p>\n<p>The current FactSet EPS consensus is $1.54 for the current fiscal year, and is $2.20 for next year.</p>\n<p>Klein wasn't alone in likening Marvell to a red-hot chip stock. \"Marvell just pulled an 'Nvidia' on the Street last night, with an unambiguous beat and raise and taking FY23 sales growth to over 30%,\" Rosenblatt Securities analyst Hans Mosesmann wrote.</p>\n<p>Marvell's report sparked at least one upgrade from a research analyst: Cowen &amp; Co.'s Karl Ackerman, who lifted his rating on Marvell's stock to outperform from market perform.</p>\n<p>\"It's hard to argue this was anything but a watershed quarter with a triad of better results, better guidance, and an expanding design pipeline that anchors a new F23 guide,\" Ackerman wrote.</p>\n<p>Ackerman cheered Marvell's recent evolution, anchored by \"portfolio-optimization\" progress that has made the company increasingly competitive, in his view.</p>\n<p>\"Marvell has transformed itself from being a fast-follower to a market leader of providing semi-custom, integrated ICs on leading-edge silicon that address bandwidth friction existing in today's networks,\" he wrote, while increasing his price target to $100 from $60.</p>\n<p>The report served as validation for those who had already taken bullish views on the stock and are now bringing their expectations higher. \"Taking a step back, we have been highlighting Marvell as one of the best growth stories in semis, and to this end they are clearly not disappointing,\" Evercore ISI analyst C.J. Muse wrote.</p>\n<p>Muse now sees \"a clear path to a $3.25+ earnings stretch goal in FY24,\" whereas the consensus was for $2.43 a share, he said. \"Looking out further, we believe that the $4.00 bogey we have been discussing by CY25 is now likely conservative -- with earnings likely tracking closer to $4.25+ when all is said and done (at a minimum),\" Muse continued, while boosting his price target to $105 from $72 and keeping an outperform rating.</p>\n<p>Marvell shares have rocketed 75% so far this year, while Nvidia shares have soared 134%, AMD's stock has rallied 56% and the S&amp;P 500 has risen 20%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Marvell will be 'in the same camp' as AMD, Nvidia after 'one of the best' semiconductor earnings calls</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarvell will be 'in the same camp' as AMD, Nvidia after 'one of the best' semiconductor earnings calls\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 09:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stock jumps more than 17%, its best day since 2008, as analysts describe chip maker's earnings as 'watershed quarter'</p>\n<p>Shares of Marvell Technology Inc. experienced their best trading day in 13 years after an earnings report that led analysts to predict the chip maker's ascension into the top tier of hot semiconductor stocks.</p>\n<p>Marvell shares <a href=\"https://laohu8.com/S/MRVL\">$(MRVL)$</a> increased 17.7% Friday following the company's fiscal third-quarter earnings report, which saw Marvell top expectations for its latest quarter, issue an upbeat forecast for the current period, and offer encouraging longer-term commentary. The stock posted its largest single-day percentage gain since Dec. 3, 2008, when it rose 20.4%.</p>\n<p>Chief Financial Officer Jean Hu said on the earnings call late Thursday that she expects \"continued strong demand across our end markets and improvement in supply to drive our top line revenue growth above 30% in fiscal 2023.\" That projection generated enthusiasm, as did Marvell's January-quarter revenue forecast that implied upwards of 60% growth.</p>\n<p>The company's earnings call could have been \"one of the best (if not the best) semi conf[erence] calls I have listened to in quite some time,\" wrote Mizuho desk-based analyst Jordan Klein in a note affiliated with Mizuho's sales operations and not its research team. \"In fact, it was a GAME-CHANGER for investors and in my view squarely positions Marvell as a best-in-class GROWTH SEMI into CY22,\" he continued.</p>\n<p>Marvell \"will be in the same camp now\" as Advanced Micro Devices Inc. <a href=\"https://laohu8.com/S/AMD\">$(AMD)$</a> and Nvidia Corp. <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, he argued, amid the company's cheery growth projections and likely expectations among the bull camp for $4 a share in annual earnings power within a few years. The company has a \"clear line of sight given a backlog full of design wins that has basically locked in that growth rate\" on the revenue line, he said in his note.</p>\n<p>The current FactSet EPS consensus is $1.54 for the current fiscal year, and is $2.20 for next year.</p>\n<p>Klein wasn't alone in likening Marvell to a red-hot chip stock. \"Marvell just pulled an 'Nvidia' on the Street last night, with an unambiguous beat and raise and taking FY23 sales growth to over 30%,\" Rosenblatt Securities analyst Hans Mosesmann wrote.</p>\n<p>Marvell's report sparked at least one upgrade from a research analyst: Cowen &amp; Co.'s Karl Ackerman, who lifted his rating on Marvell's stock to outperform from market perform.</p>\n<p>\"It's hard to argue this was anything but a watershed quarter with a triad of better results, better guidance, and an expanding design pipeline that anchors a new F23 guide,\" Ackerman wrote.</p>\n<p>Ackerman cheered Marvell's recent evolution, anchored by \"portfolio-optimization\" progress that has made the company increasingly competitive, in his view.</p>\n<p>\"Marvell has transformed itself from being a fast-follower to a market leader of providing semi-custom, integrated ICs on leading-edge silicon that address bandwidth friction existing in today's networks,\" he wrote, while increasing his price target to $100 from $60.</p>\n<p>The report served as validation for those who had already taken bullish views on the stock and are now bringing their expectations higher. \"Taking a step back, we have been highlighting Marvell as one of the best growth stories in semis, and to this end they are clearly not disappointing,\" Evercore ISI analyst C.J. Muse wrote.</p>\n<p>Muse now sees \"a clear path to a $3.25+ earnings stretch goal in FY24,\" whereas the consensus was for $2.43 a share, he said. \"Looking out further, we believe that the $4.00 bogey we have been discussing by CY25 is now likely conservative -- with earnings likely tracking closer to $4.25+ when all is said and done (at a minimum),\" Muse continued, while boosting his price target to $105 from $72 and keeping an outperform rating.</p>\n<p>Marvell shares have rocketed 75% so far this year, while Nvidia shares have soared 134%, AMD's stock has rallied 56% and the S&amp;P 500 has risen 20%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","MRVL":"迈威尔科技"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188787815","content_text":"Stock jumps more than 17%, its best day since 2008, as analysts describe chip maker's earnings as 'watershed quarter'\nShares of Marvell Technology Inc. experienced their best trading day in 13 years after an earnings report that led analysts to predict the chip maker's ascension into the top tier of hot semiconductor stocks.\nMarvell shares $(MRVL)$ increased 17.7% Friday following the company's fiscal third-quarter earnings report, which saw Marvell top expectations for its latest quarter, issue an upbeat forecast for the current period, and offer encouraging longer-term commentary. The stock posted its largest single-day percentage gain since Dec. 3, 2008, when it rose 20.4%.\nChief Financial Officer Jean Hu said on the earnings call late Thursday that she expects \"continued strong demand across our end markets and improvement in supply to drive our top line revenue growth above 30% in fiscal 2023.\" That projection generated enthusiasm, as did Marvell's January-quarter revenue forecast that implied upwards of 60% growth.\nThe company's earnings call could have been \"one of the best (if not the best) semi conf[erence] calls I have listened to in quite some time,\" wrote Mizuho desk-based analyst Jordan Klein in a note affiliated with Mizuho's sales operations and not its research team. \"In fact, it was a GAME-CHANGER for investors and in my view squarely positions Marvell as a best-in-class GROWTH SEMI into CY22,\" he continued.\nMarvell \"will be in the same camp now\" as Advanced Micro Devices Inc. $(AMD)$ and Nvidia Corp. $(NVDA)$, he argued, amid the company's cheery growth projections and likely expectations among the bull camp for $4 a share in annual earnings power within a few years. The company has a \"clear line of sight given a backlog full of design wins that has basically locked in that growth rate\" on the revenue line, he said in his note.\nThe current FactSet EPS consensus is $1.54 for the current fiscal year, and is $2.20 for next year.\nKlein wasn't alone in likening Marvell to a red-hot chip stock. \"Marvell just pulled an 'Nvidia' on the Street last night, with an unambiguous beat and raise and taking FY23 sales growth to over 30%,\" Rosenblatt Securities analyst Hans Mosesmann wrote.\nMarvell's report sparked at least one upgrade from a research analyst: Cowen & Co.'s Karl Ackerman, who lifted his rating on Marvell's stock to outperform from market perform.\n\"It's hard to argue this was anything but a watershed quarter with a triad of better results, better guidance, and an expanding design pipeline that anchors a new F23 guide,\" Ackerman wrote.\nAckerman cheered Marvell's recent evolution, anchored by \"portfolio-optimization\" progress that has made the company increasingly competitive, in his view.\n\"Marvell has transformed itself from being a fast-follower to a market leader of providing semi-custom, integrated ICs on leading-edge silicon that address bandwidth friction existing in today's networks,\" he wrote, while increasing his price target to $100 from $60.\nThe report served as validation for those who had already taken bullish views on the stock and are now bringing their expectations higher. \"Taking a step back, we have been highlighting Marvell as one of the best growth stories in semis, and to this end they are clearly not disappointing,\" Evercore ISI analyst C.J. Muse wrote.\nMuse now sees \"a clear path to a $3.25+ earnings stretch goal in FY24,\" whereas the consensus was for $2.43 a share, he said. \"Looking out further, we believe that the $4.00 bogey we have been discussing by CY25 is now likely conservative -- with earnings likely tracking closer to $4.25+ when all is said and done (at a minimum),\" Muse continued, while boosting his price target to $105 from $72 and keeping an outperform rating.\nMarvell shares have rocketed 75% so far this year, while Nvidia shares have soared 134%, AMD's stock has rallied 56% and the S&P 500 has risen 20%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":184,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693411287,"gmtCreate":1640060278217,"gmtModify":1640060952409,"author":{"id":"4093495894883950","authorId":"4093495894883950","name":"arakom","avatar":"https://static.tigerbbs.com/6e1f9b71242f06741e2b1d70506f8aaa","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4093495894883950","authorIdStr":"4093495894883950"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693411287","repostId":"2192358181","repostType":4,"isVote":1,"tweetType":1,"viewCount":690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}